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ABSTRACT OF DISSERTATION 
 
 
A MESSAGE-CENTERED APPROACH TO UNDERSTANDING  
YOUNG WOMEN’S DECISION-MAKING ABOUT HPV VACCINATION 
 
The HPV vaccine represents an important step in the primary prevention of cervical 
cancer, yet uptake rates for the vaccine remain below what is needed to establish "herd 
immunity" from the virus.  While many studies have examined both psychosocial and 
communication factors affecting HPV vaccination decisions, this study adopts a unique 
approach to understand the communication environment within which this health 
decision happens, such as the many and sometimes conflicting messages about vaccine 
efficacy and safety guiding young women's decisions.  Using the message convergence 
framework, this project identifies how further study of converging and diverging 
messages in the communication environment in which young women make their 
vaccination decision can extend research in considering optimal communication 
strategies to enhance demand for HPV vaccination.  In Study 1, 39 unvaccinated women 
participated in qualitative interviews and were asked questions in order to understand the 
important elements of the HPV vaccination communication environment that affected 
their decision (i.e., common sources and content of messages, how they discussed these 
messages "interacting" and influencing their decision).  Study 2 builds on the findings of 
Study 1 by employing an experimental design to test different message convergence 
conditions on women's intent to vaccinate (e.g., what happens when a doctor and a family 
member give conflicting information and recommendations about HPV vaccination?).  
Three hundred and nine unvaccinated women were randomly assigned to one of nine 
experimental message conditions and then assessed on behavioral intentions.  Support 
was found for the message convergence framework.  This project represents the first 
formal testing of the message convergence framework and the first time it has been used 
in the health context.  The findings from these studies are discussed in terms of the 
implications for future cervical cancer research and prevention campaigns, as well as the 
utility of the message convergence framework for other health communication research 
topics in which researchers are seeking to better understand and consider the 
communication environment when designing health behavior interventions. 
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CHAPTER 1 
HPV Vaccination 
Called one of the “purest examples” of a national public health success story by 
those in the public health sector, the introduction of the Pap test for the screening and 
early detection of precancerous cells on the cervix has been responsible for a steady 
decrease in cervical cancer deaths over the last 50 years (Edwards et al., 2005; Rust, 
Satcher, Fryer, Levine, & Blumenthal, 2010).  However, women remain vulnerable to 
cervical cancer.   In 2008, the most recent year for which national data are available, 
12,410 women were diagnosed with cervical cancer and 4,008 women died from the 
disease (U.S. Cancer Statistics Working Group, 2012).  In Kentucky, the cervical cancer 
incidence rate (8.83 per 100,000 females; 95% CI; Kentucky Cancer Registry, 2012) is 
significantly higher than the U.S. rate (7.9 per 100,000 females; 95% CI; U.S. Cancer 
Statistics Working Group, 2012), with 28 out of the 120 counties in Kentucky reporting 
cervical cancer incidence rates higher than 12.0 
With recent research revealing that 75% of cervical cancer diagnoses can be 
attributed to persistent infections of Human Papillomavirus (HPV) Types 16 and 18 
(NCI, 2008), the introduction of the HPV vaccine as the first primary prevention measure 
against cervical cancer should also be a national public health success story.  
Unfortunately, that is not the case – yet.  Two HPV vaccines are available in the United 
States; both protect against HPV Types 16 and 18, and both are given as three injections 
over a six-month period (CDC, 2010b).  The U.S. Food and Drug Administration (FDA) 
approved the quadrivalent HPV vaccine Gardasil (Merck) in 2006 for females ages 9-26 
years.  In 2009, the FDA approved the bivalent HPV vaccine Cervarix 
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(GlaxoSmithKline) for females ages 10-25 years (CDC, 2010b).   Gardasil is also 
approved for males ages 9-26 years because it provides protection against HPV Types 6 
and 11, which cause approximately 90% of genital warts, a condition that affects both 
males and females (CDC, 2010c).  Awareness of the vaccine is high in the United States, 
with one report showing more than 78% awareness among young adult women four years 
ago (Jain et al., 2009).   
Despite strong recommendations from the CDC that girls should be vaccinated at 
11 or 12 years old, uptake rates (dose 1) remain low in the United States (CDC, 2010d).  
Only 53.0% of adolescents aged 13 to 17 years have received dose 1 of the vaccine 
(CDC, 2011).  Compared to the nation, Kentucky has even lower uptake rates, with 
31.0% of adolescents aged 13 to 17 years having received dose 1 (CDC, 2010a).  
National rates are also low for adult women aged 19 to 26 years, who are thought of as a 
“catch-up group”; only 20.7% of women in this age group have received dose 1 of the 
HPV vaccine (CDC, 2012). 
The three-dose schedule of the vaccine presents an additional challenge, with 
adherence rates (completion of doses 2 and 3 within the appropriate time frame of sixth 
months) lower than dose 1 acceptance rates.   Nationally, 34.8% of adolescents aged 13 
to 17 years have received doses 2 and 3 of the vaccine (CDC, 2011).  In Kentucky, 19.5% 
of adolescents aged 13 to 17 years have received doses 2 and 3 (CDC, 2010a).  And 
while no national data on adult women are currently available, it is reasonable to assume 
that adherence rates are low for this group.  
Even with these relatively low uptake and adherence rates since the introduction 
of the first HPV vaccine in 2006, HPV incidence rates are dropping.  A recent study 
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compared HPV prevalence data from the pre-vaccine era (2003-2006) to the post-vaccine 
era (2007-2010) and found that for some age groups, the types of HPV that are prevented 
from this vaccine are decreasing in incidence (Markowitz et al., 2013).  Specifically, for 
females aged 14-19 years, HPV types 6, 11, 16, and 18 (all the types included in the 
quadrivalent HPV vaccine, Gardasil) decreased by more than half from the pre-
vaccination era to the post-vaccination era.  This suggests that the HPV vaccine has been 
especially successful at protecting younger girls and teenagers from this disease.  
However, there was no decrease in the prevalence of these types of HPV among any 
other age group.  There are two possible reasons for this finding.  First, many people in 
the older age groups (up to age 59) have never been age-eligible for the HPV vaccine.  
Second, sexual activity is higher among older adolescents and young adult women than 
the younger age group, and therefore likelihood to contract this disease is higher.  
Therefore, despite these promising findings, I argue that it’s even more important that we 
focus on this “catch-up” group of young adult women (18-26 years old) who are still age-
eligible for the HPV vaccine and for whom we are not seeing a drop in HPV infections in 
the post-vaccination era.  In addition, in the Appalachian region, which includes  parts of 
Kentucky, Lengerich et al. (2005) suggest that the higher cervical cancer incidence rates 
are due in part to “elevated prevalence of high-risk human papillomavirus” (p. 45).  In 
sum, efforts to understand the HPV vaccination behaviors of young adult women, 
particularly those in Kentucky, require more attention. 
Research reveals a number of factors that help to explain low uptake and 
adherence rates for the HPV vaccine among young adult women who are making the 
decision to vaccinate on their own (compared to younger adolescents who may have the 
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decision made for them by a parent). Researchers have studied young women’s 
knowledge about HPV and cervical cancer and the decision to vaccinate (Cooper, 
Polonec, & Gelb, 2011; Gerend & Shepherd, 2011; Kennedy, Osgood, Rosenbloom, 
Feinglass, & Simon, 2011; Klug, Hukelmann, & Blettner, 2008); not surprisingly, poor 
knowledge about HPV (e.g., what it is, how it causes cervical cancer, how easily it is 
spread, etc.) was shown to be a barrier to vaccine uptake (Dillard & Spear, 2010; Licht et 
al., 2010).  Previous work has also focused on attitudes, facilitators, and barriers to 
vaccination (Conroy et al., 2009; Crosby, Schoenberg, Hopenhayn, Moore, & Melhan, 
2007; Daley et al., 2010; Dillard & Spear, 2010; Jain et al., 2009; Mills, Vanderpool, & 
Crosby, 2011a; Patel et al., 2012; Sandfort & Pleasant, 2009; Short et al., 2010).  
Consistent with social cognition models like the Theory of Reasoned Action (Fishbein & 
Ajzen, 1975; Montaño & Kasprzyk, 2008), negative attitude about the vaccine was 
associated with lower vaccination or vaccination intention (Daley et al., 2010; Short et 
al., 2010) and positive injunctive norms were related to vaccination intention (Dillard & 
Spear, 2010; Patel et al., 2012).  Some of this previous research conflicts, and it remains 
unclear whether a previous positive Pap test result (suggesting an increased risk for HPV) 
is more (Crosby et al., 2007) or less likely (Conroy et al., 2009) to motivate young adult 
women to vaccinate.  Previous research also establishes demographic differences in 
vaccine uptake and adherence among this population age group, such as race/ethnicity 
(Bednarczyk, Birkhead, Morse, Doleyres, & McNutt, 2011; Dempsey, Cohn, Dalton, & 
Ruffin, 2011; Kessels et al., 2012), education and socioeconomic status (Jain et al., 2009; 
Tiro et al., 2012), and geography (Crosby, Casey, Vanderpool, Collins, & Moore, 2011; 
!
5 
Franceschi, 2010).    For example, Crosby, et al. (2011) found that rural women were less 
likely to get vaccinated that their urban counterparts in Kentucky. 
Health communication scholars have also tackled this problem on different levels 
of analysis.  Some scholars have focused on interpersonal sources of influence on 
vaccination decisions, such as the conversations about HPV vaccination with healthcare 
providers (Cermak, Cottrell, & Murnan, 2010; Roberto, Krieger, Katz, Goei, & Jain, 
2011), with family members such as mothers (Shafer, Cates, Diehl, & Hartmann, 2011), 
and with female friends (Miller-Ott & Durham, 2011).  Others have focused on media 
sources of information about HPV vaccination and cervical cancer prevention (Briones, 
Nan, Madden, & Waks, 2012; Correa & Harp, 2011; Forster, Wardle, Stephenson, & 
Waller, 2010; Grantham, Ahern, & Connolly-Ahern, 2011; Quintero Johnson, Sionean, & 
Scott, 2011; St. John, Pitts, & Tufts, 2010).  Alternatively, some have used 
communication theory and message design strategies to conduct formative research for 
and to evaluate pro-HPV vaccination messages through both lab and field experiments 
(Cohen & Head, 2013; Cohen et al., under contract; Kelly, Leader, Mittermaier, Hornik, 
& Cappella, 2009; Krawczyk et al., 2012; Nan, 2012a, 2012b; Ngondo, 2009; Shafer et 
al., 2011; St. Germaine-Madison, 2009; Vanderpool et al., 2013). 
The vast amount of past research on this topic reveals many important factors that 
influence a young woman’s decision to receive the HPV vaccine, and many of these 
findings have been incorporated into public health campaigns to increase vaccination.  
But given the relatively low uptake and adherence rates in the United States, researchers 
may be missing an important avenue for studying this health behavior.  No previous 
research has examined the communication environment in which HPV vaccines are 
!
6 
introduced to and discussed by audiences.  An approach to understanding the number of 
HPV vaccine messages a young woman is exposed to, the way she processes those 
messages, and the effect that has on her decision to vaccinate can enhance our 
understanding of HPV vaccination behaviors. 
This approach may be especially prudent given the context of the vaccine’s 
introduction in the United States.  First, in the United States the two HPV vaccines were 
approved and recommended for use in different populations (i.e., different age groups, 
males and females) in stages over a few years (CDC, 2010b, 2010c).  Second, given the 
seemingly rapid approval of these HPV vaccines in the eyes of the public, many 
individuals had questions about the safety and efficacy of this prophylactic despite 
clinical trials that showed high efficacy and low rates of adverse events associated with 
vaccination (Castellsague et al., 2011; Freed, Clark, Butchart, Singer, & Davis, 2010; 
Gerhardus & Razum, 2010; Haupt & Sings, 2011).  Third, given that HPV is a sexually 
transmitted disease, a decidedly political and at times religious public discourse 
developed about the HPV vaccination, especially in light of the recommendation that 
girls should be vaccinated as early as nine years old (Casper & Carpenter, 2008; Gostin, 
2011).   
The history of HPV vaccination in the United States leads to a communication 
environment in which there are “multiple messages that compete for acceptance” that 
originate from a variety of sources (Sellnow, Ulmer, Seeger, & Littlefield, 2009, p. 7).  
As previously stated, past studies have examined both psychosocial and communication 
factors affecting HPV vaccination decisions, but no work has attempted to understand the 
larger communication environment within which this health decision occurs.  This 
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environment includes messages originating from different sources, like friends, family 
members, social media, mass media, political figures, and healthcare providers.  
Additionally, the content of these messages varies.  Messages may be positive and 
encourage vaccination, negative and discourage vaccination, or ambiguous and cause 
uncertainty.  This variable communication environment around HPV vaccination, 
combined with the low uptake and adherence rates for young adult women, is ripe for 
study from a message convergence theoretical perspective, which takes into account how 
these messages interact for young women, how they process these multiple messages, and 
the effect these messages have on their vaccination decisions. 
Project Overview 
To address these concerns, the overarching purpose of this research project is to 
employ the message convergence framework (MCF; Sellnow et al., 2009) as a lens to 
understand the communication environment around HPV vaccination and the effect this 
communication environment has on HPV vaccination decisions for young adult women.   
 Chapter 2 presents the message convergence framework, a model that outlines 
how messages and message sources work together in a communication environment, as 
an alternative approach to past health behavior change research traditions.   Rather than 
focusing on psychological predictors (e.g., attitudes, beliefs) or individual 
communication predictors (e.g., a message from a friend), both of which have been 
address in a plethora of previous research, the MCF considers how multiple 
communication predictors may influence behavior.  Additionally, exemplification theory 
offers a complementary theory to the MCF in that it enhances an understanding of how 
multiple messages are processed.  After reviewing how these two theories can help 
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researchers better understand communication about HPV vaccination, the chapter 
concludes with two research questions that guide Study 1 of this project.   
Chapter 3 addresses the first study in this research project.   Study 1 serves as 
formative research for this project since this is the first time the MCF is being used in 
health behavior research.  Thirty-nine unvaccinated women participated in semi-
structured interviews about their decision not to vaccinate; women were asked to discuss 
past conversations and sources of information about HPV vaccination that influenced 
their decision.  The study applies the MCF as a sensitizing framework for analyzing the 
transcripts from these interviews, and the findings from Study 1 provide the foundation 
for understanding what the HPV vaccination communication environment looks like for 
young adult women.  Participants identified major sources of information, the typical 
messages received from those sources, and finally, participants discussed how those 
messages and message sources interacted to affect their perceptions of the HPV vaccine 
and their decision to vaccinate.  The chapter concludes with a discussion of the findings 
and limitations of Study 1. 
Chapter 4 details the implications from Study 1 findings and tackles the “next 
step” of addressing how young women process multiple messages about HPV 
vaccination, especially in situations in which messages converge (i.e., agree), diverge 
(i.e., disagree), or have mixed convergence/divergence characteristics (i.e., some parts of 
the message agree and some parts disagree).  While young women were able to voice 
how this message interaction occurred through the recall interview technique used in 
Study 1, this idea of message interaction (or, convergence) in line with the MCF has 
never been empirically tested.  To inform an empirical test of MCF, Study 2 borrows 
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several tenets from dual-process models of message processing, especially the notion of 
central and peripheral processing.  In an environment of multiple messages, it would be 
impossible and improbable for an individual to exert the necessary cognitive effort to 
centrally process all messages.  Therefore, Study 2 aims to discover what message and 
source cues young adult women use when encountering persuasive HPV vaccination 
communication.  Specifically, Study 2 considers how perceptions of source credibility, 
perceptions of argument strength, and past conversations with a source play a role in 
persuasion within the context of HPV vaccination.  Moving one step further, Study 2 
explores the role of these variables when a young woman is confronted with more than 
one message about HPV vaccination.  Ultimately, the goal of Study 2 is to empirically 
test the MCF in the context of HPV vaccination communication to discover under which 
conditions persuasion is more likely to occur. Throughout Chapter 4, I pose research 
questions and hypotheses for Study 2.  
Chapter 5 describes the detailed methods and results for Study 2. Three hundred 
and nine unvaccinated women were randomly assigned to one of nine message conditions 
in which they received a message from a mother source and a message from a doctor 
source, which was a modified approach to recreating the HPV vaccination 
communication environment of multiple messages.  Based on the “typical” messages 
these sources use, as identified in Study 1, participants found themselves in message 
conditions in which the mother/doctor messages converged, diverged, or were mixed the 
on content and the recommendation to receive/not receive the HPV vaccine.  Because 
persuasion attempts were both positive (i.e., receive the vaccine) and negative (i.e., do 
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not get the vaccine), behavioral intent to follow the source’s recommendation (i.e., 
vaccinate, do not vaccinate) served as the primary outcome measure for Study 2.   
Chapter 6 includes a discussion of the overall findings from this research project, 
implications for future work, and an explanation of the limitations of this project.  First, I 
consider how the findings from these studies can be understood in terms of the effects of 
multiple sources and messages on vaccination decisions.  Specifically, I address the two 
main outcomes (i.e., participants perceptions of a fictitious other “Sarah’s” likelihood to 
follow a source’s recommendation and participants ratings of their own likelihood to 
follow a source’s recommendation) in relation to perceived source credibility, perceived 
argument strength, participants’ experiences with past communication about this topic, 
and the message condition they were assigned to.  These findings have implications for 
future cervical cancer prevention campaigns – including ones designed for the important 
sources of influence (e.g., mothers, health care providers).  Second, the chapter illustrates 
the implications of using the MCF to understand this health topic from an ecological 
perspective (rather than focusing on one or two predictors of vaccination).  I argue that 
this framework has utility for other health communication research topics in which 
researchers seek to consider the communication environment when designing health 
behavior interventions.  Finally, I address the limitations for this research project which 
include participant factors (e.g., all participants were college students enrolled at one 
university in Kentucky) and method factors (e.g., limited formative research, struggles 
with designing an effective test of the MCF). 
!
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CHAPTER 2 
Study 1 Theoretical Framework 
  What sets health communication researchers apart from other health behavior and 
social science researchers is our focus on the processes and effects of communication in 
changing health behavior. This includes an understanding of the health message, source 
of the message, and message channels but also an understanding of the message recipient.  
As noted by Witte (1995), both source variables and message variables influence whether 
an audience member accepts a message and is then motivated to act on it.  For example, 
health communication researchers commonly value the influence of source characteristics 
(Ancker et al., 2009; Clayman, Manganello, Viswanath, Hesse, & Arora, 2010) and 
message characteristics (Gray & Harrington, 2011; Greene & Brinn, 2003; O'Keefe & 
Jensen, 2008; Quick & Bates, 2010) on health behavior.  Researchers often employ a 
factorial experimental design for a message testing study by using source characteristics 
(e.g., source credibility, source similarity, source likeability) combined with message 
characteristics (e.g., gain-loss frame, evidence format; Anderson & McMillion, 1995; 
Chaiken, 1980; Jackson, 1994; Jones, Sinclair, & Courneya, 2003; Major & Coleman, 
2012; Millar & Millar, 2000) to determine which condition is most effective at changing 
health behavior or predictors of health behavior.  In addition to paying attention to source 
and message characteristics, Witte (1995) also notes that the audience profile (i.e., 
message recipient) acts as an important predictor of whether “the message fit[s] the 
audience” (p. 149).  This need to focus on the audience – as well as the communication 
influences – points to the importance of conducting formative work with any audience 
and gathering key information like demographic and cultural variables, psychosocial 
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variables, and, especially important, pre-existing beliefs and attitudes about the health 
behavior.  Consistent with past work in line with the health belief model and other health 
behavior theories,   
If individuals regard themselves as susceptible to a condition, believe that 
condition would have potentially serious consequences, believe that a course of 
action available to them would be beneficial in reducing either their susceptibility 
to or severity of the condition, and believe the anticipated benefits of taking action 
outweigh the barriers to (or costs of) action, they are likely to take action that they 
believe will reduce their risks. (Champion & Skinner, 2008, p. 47) 
However, in researchers’ quest to (a) gain a fine-tuned understanding of specific 
communication variables and their effects on (b) a specific audience’s health behaviors 
combined with (c) researchers’ methodological need to exercise control in an 
experimental condition and isolate the influence of particular variables, what we may lose 
is the “bigger picture” of how communication can and does play a role in changing health 
behavior.  In other words, the current state of persuasive health message design research 
may privilege too much a micro-level understanding of communication influences on 
health behavior and fail to account for the macro-level influences of many 
communication influences on health behavior.  Therefore, in this chapter, I will further 
describe the need to consider the communication environment (rather than the effect of 
one or two source/message variables) within which HPV vaccination decisions happen, 
propose the message convergence framework (MCF) as the foundation for this study as 
well as the secondary role of exemplification theory, and present the first set of research 
questions that guide Study 1 (presented in the next chapter). 
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Message Convergence Framework 
We live in a world where we do not suffer from a lack of communication and we 
will be exposed to many messages about any given topic.  When it comes to our health 
and decisions about health procedures, the importance of communication becomes even 
clearer because we often make decisions based on the information we hear about the 
topic.  As noted by Sellnow et al. (2009), real world situations that involve risk, like a 
decision about health, are “replete with technical experts providing multiple messages 
that compete for acceptance” (p. 7).  Many other sources, like family members, friends, 
and mass media sources, also provide messages in these situations.  In terms of 
processing these multiple messages and multiple sources, Sellnow et al. say that the 
“public must construe relevance and meaning from a given risk issue’s myriad messages 
and relationships” (p. 8).  Indeed, what may be missing from past persuasive health 
message studies is an understanding of the communication context that represents how 
people are likely to experience messages about risk, their competition and convergence, 
in the real world.   In other words, rather than studying how one message from one source 
might influence an individual, a next step is studying source and content variables 
together.   
While multiple messages may focus on a central theme (i.e., cervical cancer), the 
messages may differ on any number of characteristics (e.g., sender of the message, 
content of the message, framing of the message, accuracy of the message, timeliness of 
the message, etc.). Individuals exposed to these messages will process these multiple 
messages and will try to make sense of them; that sense-making process is complicated 
by how similar and different the messages are and by the individual receiver’s frame of 
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reference (e.g., beliefs, attitudes, psychosocial variables, previous experience with this 
health issue).  On the basis of these ideas, Sellnow et al. developed the message 
convergence framework (MCF) as a way to understand how messages on a similar topic 
interact and affect decision-making. 
 Sellnow and colleagues say they developed this framework because they wanted 
to take a message-centered approach in their research “as a means for understanding, 
evaluating and improving risk communication” (Sellnow et al., 2009, p. 3).  They argue 
that “the interactive nature of risk communication, in tandem with the multiple, often 
conflicting messages on any given risk issue, leads us to view risk communication as a 
process of interacting arguments” (p. 10).   Much like a large majority of the work in 
health communication, which focuses on outcomes (i.e., changes in beliefs, attitudes, or 
health behaviors), previous models of risk focused on outcomes such as financial costs, 
population-level behavior trends, and from a more social scientific perspective, 
psychological variables that may influence individuals’ behavior in reaction to risky 
situations.  Sellnow and colleagues posit that this new framework, which focuses on the 
communication environment in times of risk, adds to our understanding of risk in a way 
that “complements” previous models.  As will be shown in the next few sections, the use 
of the MCF complements existing health behavior and communication theories as well. 
The message convergence framework stems from a rhetorical foundation, notably 
work by Perelman and Olbrechts-Tyteca (1969).  These authors posit that within a 
communication environment, the following interactions occur: 
• Interaction between various arguments put forward 
• Interaction between the arguments and the overall argumentative situation 
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• Interaction between the arguments and their conclusion  
• Interaction between the arguments occurring in discourse and those that are about 
the discourse (p. 460). 
Sellnow and colleagues adopted this notion of argument interaction in their work.  
Specifically, message convergence occurs “when distinct bodies of knowledge overlap, 
resulting in some capacity of agreement” (p. 12); ultimately, a high degree of message 
convergence, or overlap, is desired because it reduces uncertainty for individuals when 
they are trying to make sense of a topic.  In other words, when individuals hear consonant 
messages from different sources over time, they can feel more certain about the 
information – and, more importantly, the recommendations – contained within those 
messages because the messages are essentially reinforcing each other.  When message 
divergence occurs and individuals encounter messages from multiple sources that contain 
dissonant information, individuals engage in sense making by evaluating the competing 
claims contained in various messages.  As noted by Sellnow and colleagues, “observers 
collect and contemplate information from a variety of sources…and discuss this 
information…these discussions lead to a variety of options” or response options (p. 13).  
In other words, individuals may need to exert more cognitive effort to evaluate divergent 
messages because they must evaluate these competing claims.  
Finally, when messages or arguments interact (i.e., individuals encounter more 
than one source delivering a message about a similar topic; these messages may interact 
in that they converge or diverge), individual and group level factors may affect how 
much weight is given to one message (or type of message) over another.  These factors 
may include demographic and cultural variables, perceived credibility and similarity of 
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the source delivering the message, personal relevance to the topic being communicated, 
etc. (Sellnow et al., 2009).  In some situations, messages may have congruence (complete 
consensus or single-mindedness), mutual exclusivity (one argument “wins” over all other 
arguments), dominance (one message, or message sender, is given more attention in the 
public discourse), and the burden of multiple sources (the need to process the interaction 
of many arguments).  Figure 2.1 depicts a simple Venn diagram to illustrate how 
messages from different sources (each circle) interact and have varying degrees of 
convergence. 
 
  
The MCF was developed as a framework for understanding and ultimately managing risk 
about a given topic; it stems from a public relations mindset. As such, the limited amount 
of previous work using this framework has centered on understanding the multiple 
messages about a time of risk (i.e., a crisis) and using the MCF as a “best practices” 
Figure 2.1  
Message Convergence 
 
 
Figure 2.1 Venn Diagram depicting how multiple bodies of knowledge (messages) interact, 
taken from Sellnow, T. L., Ulmer, R. R., Seeger, M. W., & Littlefield, R. S. (2009). 
Effective Risk Communication: A Message-Centered Approach. New York: Springer. 
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approach to managing those messages for the public.  For example, Sellnow, Ulmer, 
Seeger, Littlefield, and Wood (2009) examined how a water company in Milwaukee dealt 
with an outbreak of the disease cryptosporidiosis, which is characterized by nausea, 
diarrhea, and fever, and is caused by an infestation of parasites in the water supply.  They 
used the MCF to understand how multiple sources, such as the water company and city 
officials, were not communicating competently with each other or with the public 
properly to control the situation and keep people healthy.  In this case study, they were 
able to identify gaps in communication, how multiple messages from different sources 
were providing conflicting information, and ultimately, provide recommendations for 
improving the communication in future situations. 
In terms of health communication, this framework has utility in our field for at 
least two major reasons.  First, it can provide a novel way for health communication 
scholars to understand how individuals process the variety of messages about any given 
health topic to which they are exposed, how those messages interact, and how that affects 
their health decision-making.  While the focus of much persuasive health communication 
research has been on creating and testing messages, this complementary approach allows 
for the researcher to step back and examine the existing persuasive messages that an 
individual may already have seen or heard.  Second, for many risk and crisis 
communication situations, there is a temporal element in which there is a marked 
beginning and ending of messages.  For example, Anthony and Sellnow (2011) examined 
how Gulf Coast residents responded to different messages (and different channels, such 
as local vs. national media) in the aftermath of Hurricane Katrina.  Obviously, the 
majority of messages for this situation were concentrated in one time period shortly 
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before and for several months after the hurricane.  In other words, times of risk (i.e., a 
crisis) involve a temporal element that, to some extent, limits the amount of messages an 
individual is exposed to as well as limits the amount of time within which an individual 
must make a decision (e.g., to evacuate).  On the other hand, a framework like MCF is 
essential in the context of health communication in which there may be no temporal 
element; people may be exposed to messages about a health topic for decades (e.g., 
smoking, exercise, the harms of drinking, whether eggs are good for you, etc.). 
Exemplification Theory 
What is also missing from previous work using the MCF is how multiple 
messages interact to influence a person’s thoughts and actions.  One theory that provides 
a complementary view of this phenomenon is exemplification theory.  Developed and 
mostly studied in the context of mass media messages, exemplification theory helps us 
understand how people receive multiple messages about a common topic and then how 
an individual processes those messages and forms perceptions about the topic.  While 
MCF tells us that messages about a particular phenomenon can and do diverge and 
converge and how that may affect an individual’s actions, exemplification theory 
provides a foundation for understanding the cognitive and affective processing of those 
multiple messages.  This theory privileges the notion of exemplars about a topic having a 
particularly strong influence on individuals’ perceptions about the general topic.  For 
example, why would a person pay more attention to one message compared to another?  
And how does a person compare a new message to the messages they’ve already received 
about this topic?   
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Exemplification theory provides a framework for addressing these questions.  
Zillman (2002) posits that “essentially for reasons of cognitive economy, organisms had 
to find ways of extracting experiential chunks from the continual flow of information 
about their environments” (p. 19).  A trained media scholar, Zillman was especially 
interested in seeing how exposure to singular stories about a topic, which he labeled 
exemplars, would affect an individual’s perceptions about the topic in general.  The 
theory operates with three main assumptions: 
1. Comprehension, storage, and retrieval of elemental, concrete events are 
generally superior to those of complex, abstract events. 
2. Events of consequence attract more attention and are more vigorously 
processed than irrelevant events. 
3. The incidence of events of the same kind is coded, and basal quantitative 
assessments are made on the ground of this coding. (Zillman, 2002, p. 25-
26) 
The theory also relies on two cognitive processing assumptions.  The representativeness 
heuristic stipulates that base rate information (i.e., facts or statistics about a certain topic) 
might mean less to a person than personal stories they hear about the topic.  In the same 
way, exemplars will vary with regard to how much they represent (or misrepresent) the 
base rate information.  The availability heuristic stipulates that exemplars that come to 
mind quickly are more influential; access to these exemplars can be influenced by 
recency and frequency of the exemplars. 
 Although I make the argument here that exemplification theory is a useful 
complement to MCF, there are some limitations in how this theory can be used for this 
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research.  First, most if not all of the research on exemplification has looked at media 
messages (Cox & Cox, 2001; Yu, Ahern, Connolly-Ahern, & Shen, 2010; Zillman, 1999, 
2002).  Scholars have given exemplars heard from interpersonal sources like friends and 
family little attention.  Second, exemplification research has focused solely on the 
message and paid little attention to the persuasive impact of the source.  One exception is 
a study by Aust and Zillman (1996) in which the source, who was portraying the victim 
of a crime, delivered the message in a calm manner or in an emotionally charged manner.   
The emotionally charged condition elicited from participants a stronger perception of risk 
to individual and that crime was a more severe issue compared to other conditions.  Still, 
the only source variable manipulated in this study was emotional delivery, and the 
researchers failed to examine any number of other source variables that may have made a 
difference in message processing.  Third, and perhaps most important, exemplification 
research focuses on cases or exemplars of events about other people and then studies how 
the aggregation of those exemplars in the mind of an individual might affect his or her 
perception of that topic.  However, for many messages that one hears or sees, the 
message might be directly targeted at that individual.  One study by Brosius and Bathelt 
(1994) hinted at this idea in a research project of five experiments using exemplification 
theory as a guiding framework.  Each experiment consisted of a variety of messages 
about a topic and varied on vividness of language and representativeness of base rate 
information.  Four topics were covered on a fictitious radio program during the course of 
the experiment; those topics were wine shortages in the area, replacement of coin pay 
phones with credit card pay phones, type of food in a nearby university cafeteria, and the 
obligatory use of classroom computers in the same nearby university.  The authors claim 
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they varied the topics in terms of issue involvement (the experiment was done with 
university students, so the two university-related topics would be of more interest to 
them), which does somewhat address the notion of messages related to the individuals.  
However, other than examining the effect of general news stories about community 
issues that may or may not affect an individual, this and other research has failed to 
examine the exemplification of messages directed at an individual. 
In the context of the current research project on message convergence dealing 
with HPV vaccination, exemplification theory provides some important guidance.  First, 
this is one of the only communication theories that focus on processing multiple 
messages and, in fact, privileges the idea that there will be multiple messages about a 
topic that have some degree of similarity (i.e., they are about the same topic) but will also 
differ on important variables that may make the differences in what a person decides to 
do.  In the case of HPV vaccination, this is relevant given the large amount of varied 
information that is communicated about this topic.  Second, exemplification theory does 
not put limits on the amount of messages that can be considered or when those messages 
were received.  In fact, this theory deals specifically with aggregation of many messages 
and, as noted by Zillman (2002) “closer examination of the projected longitudinal 
influence [of exemplars]…seems especially important….months and perhaps years might 
be more appropriate units of time…[for exemplars] to impose, if not dictate, the 
perception of issues” (p. 39).  As previously noted, for a health communication topic like 
HPV vaccination, young women may hear many messages over a period of time.  Third, 
much of the research in exemplification has focused on messages or stories about risk, 
which is in keeping with the current project.  While a full summary of the research is not 
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practical (see Zillman & Brosius, 2006 for a full review), especially given the focus on 
mass media exemplars, Zillman (2006) concludes that “the involvement of just one 
emotional exemplar in an otherwise highly fact-focused [environment]…is capable of 
elevating assessments of risk to others and self.” (p. 227).  He goes on to say that we 
must be attuned to the effects of certain exemplars that draw attention to risk, change 
beliefs about risk, and cause an individual to feel a greater need to act to protect 
themselves from this risk.  In this way, exemplification theory is perfectly suited to help 
researchers understand the potential persuasive impact of one or two messages about 
HPV vaccination among a milieu of other messages. 
In the case of HPV vaccination, the decision to adopt or not adopt this 
prophylactic innovation is a complex one that happens in a milieu of messages over time; 
these messages contain information about a variety of risks such as risk of the vaccine, 
risk of HPV, and risk of cervical cancer.  Our previous work with young adult women in 
Kentucky has revealed some interesting findings in terms of decision-making about this 
vaccine situated within a communication environment full of persuasive messages 
(Cohen & Head, 2013; Cohen et al., under contract; Head & Cohen, 2012; Head, Mills, & 
Vanderpool, under review; Mills, Head, & Vanderpool, under review).  For example, 
some young women in Kentucky have reported hearing messages encouraging them to 
get the HPV vaccine from a variety of sources including mothers and family members 
(Mills, Head & Vanderpool, 2013), healthcare providers (Head, Vanderpool, & Mills, 
2013), and mass media sources such as the Gardasil advertisements (Cohen & Head, 
2013).  In contrast, women also heard many negative stories about HPV vaccination.  For 
example, young women reported how peers discussed their personal HPV vaccination 
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experience (e.g., how painful the shot was, what types of side effects they experienced) 
and how that information influenced their own decision (Head & Cohen, 2012).  In 
another study, women attributed knowledge about dangerous side effects of the vaccine, 
such as affecting a woman’s ability to have children and even women dying from the 
vaccine, to mass media sources (Mills, Head, & Vanderpool, 2013).  Finally, some young 
women recounted conversations with mothers and healthcare providers in which they 
were advised not to get the vaccine (Cohen & Head, 2013; Head & Cohen, 2012).  In the 
case of mothers (in this geographic area in particular), religious beliefs may affect their 
willingness to believe their daughters are at risk for an STD, although some of our 
research suggests mothers are more positive about vaccination for older adult daughters 
(Behringer & Friedell, 2006; Kahn et al., 2009; Mills, Head, & Vanderpool, 2013).  For 
healthcare providers, these types of messages are consistent with other research in which 
Appalachian pediatricians are less likely than non-Appalachian pediatricians to 
recommend the HPV vaccine to their patients because of lower perceived susceptibility 
(Krieger, Katz, Kam, & Roberto, 2011). 
The cumulative findings of these and other studies are the impetus for the current 
project. Young women are reporting many messages about HPV vaccination that they 
hear from a variety of sources, and it is unclear what impact the accumulation of these 
messages is having on vaccination decisions.  Therefore, in addition to using the kind of 
research described in the previous paragraph as formative research for designing 
persuasive health messages (which is what it was originally used for), these findings also 
suggest that researchers are missing an important component of formative work and of 
the complex environment within which health decision making happens – what is the 
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persuasive impact of the HPV vaccination messages that young women are already 
exposed to in their communication environment?  In other words, how do women sort 
through various existing messages from various sources and ultimately decide which 
source/message to trust?  
Cline (2003) addresses this notion of multiple messages well when she says health 
communication should be seen as “a matrix of formal and informal communication 
contexts in which planned and incidental everyday messages abound, in both mediated 
and interpersonal forms” (p. 286).  She goes on to argue that, especially in the case of 
informal interpersonal communication, it’s important to understand how strong these 
messages can be in influencing health behavior.  In a case study looking at the role of 
informal, interpersonal communication on HIV/AIDS behaviors (e.g., testing, disclosing 
a diagnosis, negotiating condom use, etc.), Cline found that most of the desired behavior 
changes by the participants were facilitated by interpersonal communication, not 
mediated messages. She issues a call to fellow health communication researchers to 
“attend to the sometimes more difficult-to-capture factors that influence health,” such as 
those informal messages heard through interpersonal channels (p.  304).  She also argues 
that in doing research that pays attention to these issues, we can move away from a 
researcher-initiated agenda toward a participant-centered agenda in designing our 
interventions.  In other words, when we understand health and health behaviors in terms 
of how individuals creating meaning and communication about these topics from a 
holistic perspective, we can design interventions that privilege the voice and life world of 
the participant.  These messages may end up being more effective, and in the case of 
HPV vaccination, this may be just the approach that is needed to increase vaccine uptake. 
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In sum, the MCF can be used to understand the communication environment 
within which an individual makes a decision about a particular topic.  This framework 
has great potential for expanding researchers’ understanding of communication processes 
and moving beyond studying one or two messages and their effect on individuals, 
especially in the field of health communication.  Additionally, exemplification theory 
informs us that there are certain message characteristics that may influence an 
individual’s recall and the subsequent persuasive power of that message.  However, 
because these theoretical frameworks have not been used in the context of health 
communication about HPV vaccination specifically, formative work – in line with 
Cline’s argument – needs to be done in order to understand the communication 
environment around this topic beyond the previous work reported above.  In other words, 
to really study the way in which young women sort through various messages from 
various sources – and ultimately figure out which messages and sources have the most 
persuasive impact – researchers must first understand what that communication 
environment looks like.  Therefore, Study 1 addressed the following research questions:  
RQ1: What are the common sources, message features, and message channels 
that young adult women report hearing and seeing about HPV vaccination? 
RQ2: How do young adult women discuss these messages interacting in a 
communication context and influencing their decision to vaccinate? 
To address these questions, Study 1 takes an in-depth look at how young women 
discuss the messages they’ve encountered about HPV vaccination and allows researchers 
to understand what the HPV vaccination communication environment looks like.  Semi-
structured interviews with young adult unvaccinated women reveal the common sources 
!
26 
and messages about HPV vaccination these individuals encounter (i.e., memorable 
messages) as well their descriptions of the consonant and dissonant characteristics of 
these sources and messages.  Specifically, these interviews query young women about the 
sources and content of existing persuasive messages - or exemplars - about HPV 
vaccination. This formative work lays the foundation for better understanding HPV 
vaccination communication and shaping future research and interventions for this 
population.   
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CHAPTER 3 
Study 1 Theoretical Framework 
The primary objective of Study 1 is to better understand and explain the HPV 
vaccination communication environment for young adult women.  To address this 
objective and the specific research questions posed in the previous chapter, I used 
previously gathered interview data that was part of a larger project on various women’s 
health issues and included both vaccinated and unvaccinated women.  Examining only 
the unvaccinated women’s responses and applying the MCF as an a posteriori 
framework, I explored these young women’s recall and report of messages received about 
HPV vaccination to help elucidate the communication environment within which they 
decided against HPV vaccination.  In the following sections, I describe the participants in 
Study 1 and explain procedures for collecting and then analyzing the data.  I then provide 
a discussion about the findings and provide the reader with a list of limitations for this 
study. 
Methods 
Participants and recruitment. Participants were 39 unvaccinated women who 
spoke English and were between 18 and 26 years old.  Women were recruited from a 
large Midwestern university through two different channels: a) flyers were placed around 
campus advertising the study and women were offered a $10 iTunes gift card as an 
incentive for participating and b) a notice was put in the online recruitment site for 
students in the Department of Communication research pool and these students were 
given course credit for participating.  The majority of participants were White (n = 33), 
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with a minority of women from African-American (n = 4) and other racial/ethnic groups 
(n = 2). 
Procedures and protocol. Women contacted the principal investigator of the 
main study (Dr. Elisia Cohen) through the email address listed on the campus flyer or 
through the online department research sign-up system to sign up for the study and 
schedule an interview time.  Interviews were conducted on campus in the PI’s private 
office with the door shut, and all interviews were audio recorded.  Participants provided 
informed consent before beginning the interview and before the audio-recording 
equipment was turned on.  Interviews lasted between 10 minutes and 30 minutes, and all 
participants answered every question (even if their answer was “I don’t know.”).  
Interviews were transcribed verbatim.  Prior to analysis, the PI and I read through the 
transcripts to remove any personal identifiers before analysis began and then assigned 
each participant a pseudonym.  All study procedures were approved by the University’s 
Institutional Review Board.   
The interview data used for this study was actually previously collected as part of 
a larger study.    In returning to the original interview protocol and the interview data, we 
realized that information germane to the current study was gathered in two ways.  First, 
as part of the original study, women were asked open-ended questions about knowledge, 
attitudes, and vaccination decisions, which often included personal stories involving 
messages and message sources.  Second, women were specifically asked to recall media 
messages, conversations with family/friends, and conversations with healthcare providers 
about HPV vaccination.  We (the PI, Bethney Wilson, a research assistant on the project, 
and I) used previous literature on cancer prevention and HPV vaccination and our own 
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experience in the field to identify these questions from the original interview protocol 
that were germane to the current study.  Specific to the MCF, we were interested in 
women’s recall of messages about HPV vaccination, the sources who delivered those 
messages, and how women discussed multiple messages about this topic “interacting” in 
their communication environment.  Related, the interview questions were open-ended and 
participants were not told to put a time limit on when they heard HPV vaccination 
messages; rather, they were free to discuss any and all HPV vaccine related messages 
they had encountered in their lifetimes. 
Data analysis. The study used a deductive data analysis technique called 
provisional coding, which involves starting with a preset list of codes and allowing the 
data to inform more comprehensive codes throughout the process, to analyze the 
transcripts.  In keeping with the theoretical framing (MCF) and the research questions 
guiding the study, we (K.H. and Bethney Wilson) met to discuss the provisional list of 
codes that was informed by the MCF (Sellnow et al., 2009) and our previous experience 
and work in HPV vaccination and health communication (Cohen & Head, 2013; Head & 
Cohen, 2012; Head, Vanderpool, & Mills, 2013; Mills, Head, & Vanderpool, 2013).  
Given his expertise on the theory, we also met with Dr. Tim Sellnow to discuss the study 
and ask for guidance on employing the MCF to analyze these transcripts.   
In our initial reading of the transcripts, we coded for all message sources 
identified by participants and all HPV vaccination messages encountered by participants, 
as well as a preliminary coding of how participants discussed messages “interacting” 
(i.e., when a participant discussed two or more different sources delivering an HPV 
vaccination message). After this initial reading, we met to discuss more comprehensive 
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theoretically-informed categories based on the tenets of MCF and returned to the 
transcripts using these more developed categories.  These included source characteristics 
(e.g., how frequently or infrequently a source was mentioned in relation to other sources), 
message characteristics (e.g., typical messages heard from each source, arguments made 
within each message for or against vaccination, the vaccination recommendation within 
each message), and finally, a more sensitive reading of message interaction.  Specifically, 
we examined and coded for whether participants expressed messages diverging or 
converging and who the typical sources were in terms of message interaction.  We met 
frequently to discuss findings and in the final read-through of the transcripts we gathered 
key exemplars for each finding.   
Results 
The purpose of this study was to better understand young adult women’s HPV 
vaccination communication environment and specifically answer the following research 
questions: 1) What are the common sources, message features, and message channels that 
young adult women report hearing and seeing about HPV vaccination? and 2) how do 
young adult women discuss these messages interacting in a communication context and 
influencing their decision to vaccinate?  Findings are discussed in the next few sections. 
Primary sources of messages.   Sellnow, Ulmer, Seeger, and Littlefield (2009) 
claim that “there are many bodies of knowledge contributing to risk communication on 
any given topic” and that each of these bodies of knowledge will address the risk in 
differing ways (p. 15).  To address the first research question, we describe these bodies of 
knowledge and the typical messages participants recall hearing from each source, which 
in essence allowed us to map out what the communication environment for HPV 
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vaccination looks like.  These findings included participants’ recall of the major sources 
of information about HPV vaccination (including interpersonal and mediated sources), as 
well as the types of content in those messages (including what the typical messages 
were).  Each of these sources and the content of their messages is described below and a 
summary of these findings is found in Table 3.1 at the end of this section. 
 Mothers. One of the primary sources of HPV vaccination messages was mothers.  
Typically, participants received messages warning against the HPV vaccine from their 
mothers, and there were two main reasons for the warnings.  First, mothers warned 
against the immaturity and safety of the vaccine.  Chelsea recalled a conversation with 
her mother about whether she should get the vaccine, but her mother was worried with 
“being the first generation of the vaccine, you know possible risks haven’t been too 
widely, you know, observed.”  Similarly, Celia’s mother told her “it’s good to get it but I 
don’t know if they know like the long-term side effects from it yet.”  Chloe’s mother 
communicated her fears about the HPV vaccine by comparing it to past medications that 
were later proven harmful (e.g., Diethylstilbestrol or DES, given to women in the mid-
twentieth century).  She recalled “my mom…just said she worried about like, there have 
been things out in the past where they’ve thought were okay….then it’s turned our like 
it’s caused miscarriages and different things.”  Similar to Celia’s and Chelsea’s mothers, 
Chloe’s mother recommended waiting and said “she would rather take the chance for at 
least a little bit longer until they know like absolutely for sure.” 
 Second, some participants reported their mothers voiced anti-vaccination 
sentiments because they perceived their daughters to be sexually naïve (i.e., not sexually 
active or at least not having sexual intercourse).  Quinn recalled that both of her parents 
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told her she didn’t need to unless she was “sexually active.”  Despite reporting that she 
was sexually active (and therefore at risk for HPV), Quinn followed her parents’ advice, 
perhaps so that she wouldn’t have to confess to them that she was having sex.  Dana 
identified a conversation with her mother about vaccination in which her mother “wasn’t 
concerned about it…didn’t feel like it was a priority” because her mother believed her to 
be sexually naïve.  While Dana was sexually naïve at the time, she had since become 
sexually active (and therefore at risk for contracting HPV), but she had not decided to 
receive the vaccine. Lauren reported a similar story in which her mother said “well as 
long as you’re not being sexually active, then we don’t feel you need to get it.”  Lauren 
also said she had become sexually active after that conversation, but she had still decided 
not to vaccinate.  Interestingly, despite personally knowing they were at risk for HPV 
because they were sexually active (all of these participants and similar others were able to 
identify HPV as an STD), these women still chose not to vaccinate despite being able to 
go to the university health clinic and receive the vaccine not only free of charge, but their 
parents would not need to find out. 
Alternatively, fewer participants recalled their mothers promoting vaccination or, 
at the very least, neutrally discussing vaccination.  In the cases of positive messages, 
sometimes mothers cited family history of cancer or just general worry about cancer as a 
risk that could be mitigated by this vaccine. Tammy said her mother “told me about it and 
she was like, I…would like you to have that because cancer is prominent in our family.”  
Mary remembered her mother was very encouraging and said “you should get the vaccine 
so you don’t have cervical cancer later.”  Some participants also recalled discussing the 
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HPV vaccine with their mother, but in recalling what those conversations were like, they 
did not indicate whether the conversations were positively- or negatively-valenced. 
 Healthcare providers. Participants also identified healthcare providers as a major 
source of information about HPV vaccination.  There were three types of messages that 
participants recalled receiving from healthcare providers. First, compared to any other 
interpersonal source identified by participants, providers tended to offer women the most 
positive HPV vaccination messages and usually did so with somewhat forceful messages.  
Alyssa recalled her doctor saying “how easily you could get HPV…how like you can get 
it not through sex.  This is just a good precaution [against cervical cancer].”  (Alyssa’s 
doctor was addressing the nature of transmission of HPV in that an individual need not 
have full sexual intercourse to spread or contract the virus.)  Chloe recalled that her 
gynecologist was “very laid back” but that she was definitely “pushing it.”  Bailey 
remembered telling her doctor she wasn’t sexually active yet and the doctor “was like 
even more excited about me having the vaccine because was like, I mean then for sure 
like you would be in the clear.”  She went on to say she was “really like pushing it and I 
remember even her nurse like, coming in.”  In these cases, despite positive 
encouragement from a healthcare provider touting the benefits of this vaccine in 
preventing the risk of HPV and cancer, participants decided against vaccination. 
 Second, some providers were pro-vaccination, but participants did not feel they 
“pushed” it at all; these instances also did not result in women getting vaccinated.  Vicky 
remembered telling her doctor she had not received the HPV vaccine and the doctor said 
“okay, well you should.’  And that’s pretty much all she said about it.  It wasn’t like a 
lecture.”  Nina said she had gone to the gynecologist a couple of times and they always 
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asked her about the HPV vaccine.  When she told them she hadn’t been vaccinated, she 
remembers they gave her some information in it but “they didn’t go into description.”  
Sarah also indicated her doctor did not provide forceful messages; she recalled, “my 
gynecologist one time asked me if I had it and asked me if I wanted it and I said no both 
times and she didn’t push it any further….she did give me a pamphlet, though.”  For 
these unvaccinated women, it seems that neither very forceful nor more passive 
recommendations by providers were enough to motivate them. 
 The third type of message received from providers was similar to one voiced by 
mothers: Participants reported healthcare providers telling them the vaccine wasn’t 
necessary because they weren’t sexually active.  Rebecca recalled a conversation with her 
doctor in which she asked the doctor if the vaccine was necessary: “I asked my doctor if I 
needed it if I wasn’t having sex or anything and she said no.”  Lindsay reported a similar 
story when she asked her doctor if this vaccine was necessary for her since she wasn’t 
having sex; he told her “no it wasn’t necessary but…if you want to be on the safe side 
you can get it.”  This type of message is particularly troubling coming from healthcare 
providers who should be knowledgeable about the purpose of a vaccine – protecting 
against a virus before exposure to it (i.e., before becoming sexually active and therefore 
at risk for an STD). 
Friends and other social acquaintances. While mothers and healthcare providers 
were the dominant sources of HPV messages that these participants recalled, a few 
participants reported receiving messages regarding the HPV vaccine from friends and 
other social acquaintances.  These messages generally involved conversations related to 
the vaccine itself.  Mary recalled “one of my friends said that she got it and it hurt real 
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bad.  It hurt real bad.”  Sarah said both of her best friends got the vaccine and while “one 
of them was just fine, the other one is really a[]verse to needles so she had a tough time 
getting the vaccine.”  On the other hand, a couple of participants reported these sources 
giving them pro-vaccination messages.  Teresa indicated “my best friend…she told me 
that I should.”  Celia said one of her friends had an abnormal Pap test and that her 
healthcare provider encouraged her to get the vaccine as added protection for the future; 
Celia expressed that “we were talking about that recently and about me possibly getting 
it, too.  She was just telling me about her experience with it.” 
Gardasil mass media campaign. The majority of participants were able to recall 
and identify the main theme, or catch line, from the Gardasil advertisements (i.e., “one 
less”), and these commercials represented the most common mass media source.  In fact, 
a very common response among participants, when asked when you hear the term HPV, 
what words or phrases come to mind, was “Gardasil.” While this advertisement campaign 
was arguably very effective at raising awareness and knowledge about HPV and the 
vaccine, many participants felt the commercials were not really targeted toward them.  
Olivia described the commercial as “mothers and daughters…talking about [how] you 
need to encourage your children to take the HPV vaccination.”  Vicky had a similar 
response to Gardasil advertisements; she said the ads were “like women and their like 
young daughters going on picnics and stuff, just making sure that you get the vaccine.”  
Dana remembered “it was a lot of parent, or mother and daughters together and basically 
it, I feel like it targeted more the mothers instead of the daughters.”  Nina described her 
reaction to the advertisement by saying “it’s always girls between the ages of like 11 and 
18….which is like fine I guess, but girls just go around having fun and dancing and 
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climbing trees” did not motive her as a woman over 18 to act.  In this sense, participants 
felt these advertisements were not targeting them to take action.  
 Other media sources. Beyond the Gardasil media campaign, a small number of 
participants reported exposure to messages related to the vaccine through other media 
sources.  For example, participants reported viewing news segments on the harms and 
side effects of the HPV vaccine.  Tammy even reported “there was a recent story in the 
media about an elementary school girl getting it and then she ended up dying the same 
day from it.”  Participants also cited stories that encouraged people to stop getting the 
vaccine, such as when Chloe said “I heard just recently in the news that something came 
out where they’re actually saying that you shouldn’t have gotten it and that you need to 
stop like, giving the doses.”  In these few cases, women did not identify a specific news 
source but rather used ambiguous terms like “news” or “media” to indicate the source.  
Overwhelmingly, in these few cases the messages recalled from other media sources 
were anti-vaccination in content. 
 Lack of messages.  Participants were asked to identify the main message sources 
from which they received information about HPV and the HPV vaccine. While most 
participants could identify at least one message/message source, many reported receiving 
vague messages and some reported not receiving any messages about the HPV vaccine 
when prompted (e.g., “Can you recall a time you discussed the HPV vaccine with a 
healthcare provider? Mother? Family member? Media messages?”).  There are two 
important points to make about the lack of HPV vaccination messages.  First, participants 
may not have recalled discussions they had about the HPV vaccination, particularly when 
they decided not to receive it (as was the case for all women in this study).  It may be that 
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these discussions were brief and not something that these young women could easily 
recall after they made the decision not to receive the vaccine, especially if the 
conversations happened a long time ago. Alternatively, the lack of participants reporting 
messages from some sources (e.g., Renee reported never discussing HPV or cervical 
cancer with her gynecologist!) represent real “missed opportunities” for promoting HPV 
vaccination in these women’s lives. 
 Second, when women reported a lack of messages and/or feeling like they weren’t 
well informed about the HPV vaccination, they consistently denied searching for 
information on their own.  Both Sydney and Tammy reported that healthcare providers 
did not give them a lot of information about the HPV vaccine beyond simply 
recommending it.  When asked “aside from what little she told you, have you gotten or 
looked for any other information on HPV? …on cervical cancer?” they both simply 
replied “no” with no explanation for why they did not research it further.  Renee said she 
wasn’t sure how susceptible she was to HPV and that she didn’t know “because we don’t 
know a lot about it.  We don’t research it as lengthy as we could and there’s not a whole 
lot of information out their either.”  This lack of information seeking on the part of these 
women may reflect their desire to not be vaccinated in the first place; in other words, they 
do not care to research it further because they have already decided against vaccination. 
Table 3.1 
Common HPV Vaccination Messages and Message Sources 
Sourcea Messageb 
Mothers and 
grandmothers 
The vaccine could have harmful unknown side effects. 
 
You are not sexually active so you do not need to vaccinate.  
 
Additional: Positive/neutral discussion of HPV vaccination. 
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Table 3.1 (continued) 
 
Sourcea Messageb 
Healthcare providers The HPV vaccine is a powerful tool for protecting yourself 
against this STD. (Forceful recommendation) 
 
Have you had the HPV vaccine? (Question but no 
recommendation) 
 
If you are not sexually active, you do not need to vaccinate. 
 
Gardasil 
advertisement 
Raised awareness about HPV and the vaccination. 
 
Messages not aimed at young adult women, but rather mothers of 
young girls. 
 
Other media outlets The Gardasil vaccine causes serious adverse side effects. 
 
 
Friends and social 
acquaintances 
Getting the vaccine is painful and there can be unpleasant short-
term side effects. 
 
Additional: Pro-vaccination but not forceful. 
 
Lack of messages Could not recall discussions/exposure to HPV vaccination 
messages. 
 
Denied searching for more information about HPV vaccination 
after reporting they have little information about this health 
issue.  
 
 
Note. aSources listed in order of most commonly reported. bMessages listed in order of 
most commonly reported.  Italicized verbiage represents general message content or 
interpretation of message by participants, un-italicized text represents more concrete 
examples of messages recalled. 
Message convergence in action.  Beyond simply describing the common sources 
and messages about HPV vaccination, participants also described how these messages 
interacted.  In line with the tenets of message convergence framework, the term 
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interaction describes the ways in which women explained how messages from different 
sources converged or diverged on the content of the message and the recommendation for 
or against vaccination.  Three types of HPV vaccination message “interaction” emerged 
in the findings (divergence, convergence, and still interacting), and each is described 
below. 
First, participants discussed examples of message divergence, in which 
participants perceived conflicting information and/or recommendations about the HPV 
vaccine from different sources.  In an instance of divergence, Alyssa recalled, “my mom 
was very against it, the shot, so she doesn’t want me to get it and so she was trying to 
help me explain why I shouldn’t get it but then it was, then I went to the doctor and 
she…explain[ed] why I should get it so it was kind of a decision I needed to make.”  The 
interaction of messages from mothers and healthcare providers – when the mother was 
being unsupportive and the healthcare provider was being supportive – was the most 
common instance of diverging interaction recalled by participants.  A few participants 
reported more than those two sources interacting and diverging.  Michelle wove a story 
of many sources that influenced her decision: “I would not get it unless I absolutely had 
to and my parents, my mother never pressured me to get it.  She said I should get it but I 
never really thought about it and my gynecologist actually recommended it as well but I 
just never really listened to it.  And then once I started seeing the ads, I heard about it and 
I was kind of a little bit more, I didn’t really want to do it.  And then I had friends that got 
it that started like breaking out from it; like I know a girl that like had a really bad rash 
from it and stuff like that and then they were getting recalled and they were scared about 
it because they had them.  And I heard they are really painful and just I don’t like really 
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like shots at all so.”  Vicky also reported divergence about HPV vaccination from 
multiple sources, but she was vague in exactly who was saying these messages: “Some 
people say it’s necessary, some people are like if you want it, get it.  It’s not a big deal if 
you don’t get it.” 
  Though less common than instances of divergence, instances of convergence 
were also reported by participants.  These were cases in which participants perceived that 
two or more sources provided similar information about the HPV vaccination and a 
similar recommendation.  There were two types of divergence.  Participants reported 
negative-valenced convergence, such that two or more sources advocated against HPV 
vaccination. Penny recalled “well, I was going to get it and my mom worked in a medical 
office and…so she didn’t really recommend it, [and] like, the doctor recommended not 
getting it.”  Other times, participants reported this negative-valenced convergence, but 
did not provide details on the exact sources, suggesting that perhaps these were rumors.  
Beth said, “I’ve heard some things…is it that like some girls pass out or get dizzy.  
Because that’s I’ve heard that from like certain…[pause], I think there was one fatal case 
but I’m not really sure about that.”   
Participants very rarely reported positive-valenced convergence, in which two or 
more sources advocated for vaccination.  In one of those cases, Lindsay reported many 
positively-valenced sources.  She said, “I’ve heard about it through my doctor and I know 
there’s, I mean we talked about it in health class and it was freshman year of my high, in 
high school so I can barely remember what we talked about it but I know you can get a 
shot for it and there’s been lots of commercials for it so I mean I’m sure it’s probably 
good to get the shot but I haven’t gotten it but I do know people that have gotten it to 
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prevent HPV….[and] I did talk to my grandmother about it because she had seen the 
commercials, well the Gardasil and she was encouraging me to get it.”  Lindsay’s 
explanation of message convergence represents the best case scenario (many forms of 
positive encouragement), yet this did not result in Lindsay’s vaccination. 
The third type of interaction was our discovery that some participants were still in 
the process of sorting through messages and evaluating them; in essence, we (and others 
in the research community) may have falsely labeled these women as “unvaccinated.”  
Instead, there might be two groups of “unvaccinated women” – those who are decidedly 
unvaccinated and those who are still undecided.  After some women discussed the 
positive encouragement they received about the HPV vaccination and why they have still 
chosen not to receive it, many indicated they were still thinking about it (rather than, as 
we assumed, deciding against vaccination). As Nicole said, “but I don’t know because 
like I don’t know if I’m going to change my mind yet…so like right now I don’t but I 
don’t know about the future and so it might be a good precaution for me; I haven’t really 
decided.”  Alyssa also indicated she “kind of postponed it [her decision].”  Celia 
explained, “like I’ve talked to people but I just haven’t taken the step to go get it.”  
Recognizing that women may still be mulling over their decision to vaccinate as they 
process multiple messages about HPV vaccination provides an important distinction for 
women whom researchers previously labeled as just unvaccinated; instead, researchers 
may need to view women in stages of vaccination decision-making. 
Discussion 
The findings from this formative investigation using MCF to analyze women’s 
discussions of HPV vaccination decisions provide strong support for continuing this 
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work.  These results add to our understanding of this health behavior and, germane to 
communication researchers, our understandings of communication about this health 
behavior.  By having a clearer understanding of the communication environment within 
which HPV vaccination decisions are made, communication scholars can work to test 
these different messages to determine which may be the most influential.  These results 
provide two directions for additional research. 
First, these findings point to important message sources about HPV vaccination, 
as identified by young women.  Mothers and healthcare providers seemed to play the 
largest “roles” in these decisions for young adult women, with media and peers also 
playing a part in conveying information that could affect their decision.  This finding is 
consistent with previous literature that shows mothers and healthcare providers are strong 
influences on HPV vaccine decision-making (Conroy et al., 2009).  However, what this 
study adds is an understanding of the typical messages received from these different 
sources, which may help us better understand how and why these sources are influential.  
For example, mothers were more likely to focus on the risk of the vaccine, or the short 
term risk of side effects.  Alternatively, healthcare providers were more likely to focus on 
the risk of cervical cancer, or the long term risk of being infected with HPV which could 
cause cervical cancer.  The young adult women in our study recalled healthcare providers 
providing positive encouragement for vaccination more so than others.  Interestingly, 
participants recalled some instances in which both healthcare providers and mothers 
expressed messages about no risk of HPV because a young woman wasn’t sexually active 
and therefore was not in need of this vaccine.  Mass media and peer sources played a 
smaller role, with participants discussing risk of the vaccine messages (e.g., side effects) 
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as one of the main messages received from these sources.  Finally, one particularly 
important finding from this study is the lack of information seeking for some of the 
women who expressed uncertainty about the safety and efficacy of the HPV vaccine.  
This point in particular is deserving of further study, with an eye toward developing 
interventions to increase vaccination for this population. 
Second, these findings provide the first report of how young women discuss the 
interaction of HPV vaccination messages they’ve received. Only unvaccinated women 
were included in this study because these women would be the target population for any 
intervention.  Understanding how they discuss various message source/content interacting 
to persuade them to not receive the vaccine provides important insights for health 
communication researchers and practitioners.  For example, women rarely reported 
positive convergence, meaning they are recalling many anti-vaccination messages in their 
lives.  Additionally, women most often recalled and reported conversations with their 
healthcare providers and mothers, as well as how those two sources often “butted heads.”  
This suggests the importance of further study on the influence of these two sources, but in 
tandem (i.e., how they interact).  Finally, in speaking with young women who were 
unvaccinated, the finding emerged that some of these women are simply still in a state of 
deciding.  This is consistent with previous work by Prochaska and colleagues looking at 
the stages of change behavior model and the role of decisional balance (1994).  Stages of 
change is a behavior model which posits that individuals progress through a series of 
stages in their attempt to change a behavior and that interventions targeting individuals in 
certain stages can be very effective at “moving” individuals to the next stage (Prochaska 
& Velicer, 1997).  Most commonly used to study behaviors that are habitual and require a 
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long-term change (e.g., smoking, exercise), the model also has usefulness for a behavior 
like vaccination, especially in light of the findings from the present study.  Prochaska 
et.al (1994) investigated the role of a construct called decisional balance situated within 
the stage of change model across a variety of behaviors.  Decisional balance is the idea 
that an individual will scan the environment to learn about the pros and cons of a 
something (e.g., a behavior) before making a decision.  With regard to HPV vaccination, 
understanding the ways in which communication can affect a person’s decisional balance 
is an important next step.  
Limitations 
This study is not without limitations.  First, only unvaccinated women were 
included in the study.  In choosing an approach for the formative work in this dissertation 
project, in which there was limited time and resources, the decision to use previously 
collected data and focus solely on unvaccinated women seemed the best choice.  This is 
because unvaccinated women would be the target of any future HPV vaccine 
intervention.  In addition, while a traditional approach to understanding behavior change 
is to design persuasive messages based on formative work and see if behavioral 
intentions or actual behavior is affected positively, an alternative approach is to 
understand what messages may be influencing behavioral intentions or actual behavior 
negatively.  This information was gained through this approach.  However, future work 
may want to focus on using this same approach with vaccinated women to discover what 
differences exist that may have been the impetus for vaccination.  Recall that for the 
participants in this study, even receiving positive-valenced convergent messages did not 
result in their vaccination.  Further investigating the possible differences in unvaccinated 
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and vaccinated young women’s HPV vaccination communication environments may lead 
to some clues as to why these two groups differ on vaccination status.  Additionally, in 
conducting research with vaccinated, partially vaccinated and unvaccinated women, it 
may be possible to develop a typology of “vaccination stages of change” that could prove 
useful for future intervention attempts. 
Second, this interview technique relied on self-report of messages, requiring 
women to recall messages about this health topic for an undesignated amount of time. 
Some participants may not have remembered messages or message sources even if they 
had received messages. While definitely a limitation of the study, this self-report method 
is also in keeping with the tenets of exemplification theory.  If an individual easily recalls 
messages about a topic, this means that this particular message is easily accessible and 
perhaps has “superior influence” on the individual (Zillmann, 2002, p. 28).  Alternatively, 
not recalling messages about a topic from particular sources may be indicative of the low 
level of influence that message has on the individual.  In other words, this formative 
research is perhaps strengthened by a reliance on participant recall of influential 
messages, because these are the messages most ripe for study from a health behavior 
change perspective.  Related, the analysis was done on previously collected data and 
while the interview protocol did adequately address the specific research questions for 
this study, it may still be considered a limitation of this study.  Specifically, in examining 
the multiple sources of HPV vaccine messages, the frequency with which young women 
discussed certain sources (at the expense of others) could also be due to the way in which 
the questions were asked.  However, given that participants did mention a variety of 
sources and the weight of those sources (i.e., mothers and healthcare providers played the 
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largest role compared to others) is consistent with previous work in this area, this study 
can still be considered to have high external validity. 
Third, all participants were recruited from one university in the same geographic 
area.  Previous research identifying higher risks of HPV and cervical cancer with this 
population provided justification for this sample, but future work may want to focus on 
other geographic areas as well as women who chose not to go to college, as there may be 
important population differences.  
Conclusion 
The purpose of Study 1 was to gain a deeper insight of the communication 
environment around HPV vaccination in order to better understand what messages and 
sources are most influential.   The findings allowed us to identify important sources of 
information for young adult women as well as the typical messages received from these 
sources.  Additionally, the MCF allowed us to explore the interaction of these messages 
on young women’s vaccination decisions.   Continued application of the MCF can add to 
our understanding of HPV vaccination decisions.  However, in moving beyond 
application, a next step is testing the MCF to study empirically the interaction of 
messages on individuals’ behavior.  In the Chapter 4, the findings from Study 1 serve as a 
foundation for expanding HPV vaccination-related MCF research and Study 2 is 
proposed as a message testing experiment. 
!
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CHAPTER 4 
! Given the findings from Study 1 in this project, the second part of this dissertation 
project attempts to move beyond formative work outlining the communication 
environment using the MCF by empirically testing the influences of multiple risk 
messages on personal vaccination intentions. Although Study 1 successfully identified 
HPV vaccination messages and sources of those messages, Study 2 will extend theorizing 
by empirically testing these different existing messages and their influence on young 
adult women to provide important information about how to best intervene within the 
communication environment to change vaccination behaviors.  In order to have a starting 
place from which to develop interventions, researchers must identify which message and 
message source is most influential, whether that’s in encouraging vaccination or in 
discouraging vaccination. This chapter builds on the findings from Study 1 to explore the 
rationale for Study 2 and its goals of identifying the impact of young women’s 
perceptions of message content, message recommendation, and message source on their 
behavioral intent. 
Study 2 Theoretical Framework 
 A common approach to understanding, predicting, and attempting to control 
health behavior change is a reliance on social cognition models of behavior.  Per these 
social cognition models of behavior, such as those in line with the theory of reasoned 
action, we know that knowledge/beliefs and attitudes about a behavior predict behavioral 
intent, which is then posited as the most direct antecedent to behavior (Montaño & 
Kasprzyk, 2008).  In addition to our previous work in Kentucky exploring sources of 
influence on HPV vaccination, we also identified some important audience profile 
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variables at play in HPV vaccination decision-making.  Specifically, we found that some 
women, both vaccinated and unvaccinated, have serious knowledge-attitude-practice gaps 
(KAP-gaps) that suggest these women are vaccinating or not vaccinating without making 
a fully informed decision (Cohen & Head, 2013).  While the bias among public health 
officials is that a vaccine like this one is desirable, such assumptions by officials and 
vaccine program planners do not remove the need for the public to make informed 
decisions about health.   
Informed decisions are important for at least two reasons.  First, if women rely on 
what other people say about this vaccine – and act upon that information – they may not 
fully understand the risks and benefits of this innovation.  This is arguably an ethical 
issue.  Second, and related, in the case of HPV vaccination in particular, if a woman is 
not making an informed decision about vaccination (e.g., just getting the vaccine because 
someone suggested she should), it is not unreasonable to assume this could have an 
impact on her decision to return for doses 2 and 3.  In other words, these women may not 
have the preexisting attitudes and beliefs that are thought to influence behavior and, 
therefore, these traditional theoretical approaches to understanding health behaviors and 
designing interventions based on these types of theories may not be the most appropriate 
theories for understanding this behavior.   
Instead, based on our work in Kentucky, it appears that for some women, 
messages they receive from an important person in their life may be the reason they 
decide to vaccinate (or not vaccinate).  As noted in Cohen and Head (2012), 
Women prompted by their mothers or doctors to get the shot often did not have 
any knowledge or perceived risk of HPV. As Isabel V. expressed, “I have no idea 
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what it is honestly, I got the Gardasil® shot…... my mom wanted me to … but I 
don’t know anything about it.”   (p. 17) 
It is in this sense that researchers have demonstrated the importance of studying the 
communication about this topic, in addition to understanding the beliefs and attitudes 
about the health behavior.  For example, in the quote above, we see that a young woman 
trusted what her mother had to say about the vaccination and followed the mother’s 
advice, which resulted in the young woman becoming vaccinated.  From a 
communication perspective, one can see that both source (in this case, the young 
woman’s mother) and message (in this case, the mother’s argument for vaccination) 
made the difference in this young woman’s health behavior.  While this example shows 
that communicative influences can positively affect behavior (i.e., Isabel decided to 
vaccinate), there may be other young women who listen to influential sources telling 
them not to vaccinate. 
 Therefore, after studying the common messages and message sources about HPV 
vaccination (Study 1 of this project), the next step is for researchers to attempt to 
understand the ways in which young women process these messages and make decisions 
based on the information they received.  In moving beyond just identifying the common 
messages and message sources about HPV vaccination, which was done in Study 1 of 
this project, the next step is attempting to understand how young women are processing 
these messages and making decisions based off the information they receive.  
Specifically, we need to focus on perceptions of source and perceptions of messages 
about HPV vaccination.  Recall that MCF posits that source and message content 
variables (particularly how messages overlap) are important cues for an individual, and 
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exemplification theory goes one step further in saying that some message content 
variables may cause a message to have superior influence on an individual.  Consistent 
with past work on message processing, Witte (1995) notes that “although source and 
message variables can be thoughtfully considered in a central route manner, they are 
believed to act more often as variables that cue a person to accept a message, and thus 
tend to be processed peripherally” (p. 148).  In other words, rather than assuming that 
individuals extensively process and analyze every message they receive, a more realistic 
approach is to assume that individuals use shortcuts to process the many messages they 
receive on a topic.  This idea is related to the tenets of MCF and exemplification theory, 
which both privilege the idea that in an environment of multiple messages, some message 
factors and message source factors may operate as heuristics that stand out of offer 
memorable cues, whereas others do not, suggesting that messages may be processed 
differently.  Understanding how and why those messages and sources have heuristic 
value, in the context of the communication environment around HPV vaccination, is the 
underlying purpose of Study 2.  The next section delves deeper into the notion of 
message processing, specifically related to certain source and message factors. 
Message Processing 
 During the late 1970s and early 1980s, two groups of scholars were 
simultaneously developing quite similar message processing models: Petty and Cacioppo 
presented their elaboration likelihood model (1981, 1986) and Chaiken presented her 
heuristic-systematic model of information processing (1980).  These two communication 
models postulate that under certain conditions, individuals may use a great amount of 
cognitive effort to systematically or centrally process a persuasive communication, and in 
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these cases, persuasion is thought to be stronger and more lasting.  Alternatively, 
individuals may use minimal cognitive effort to heuristically or peripherally process a 
persuasive communication and in these cases, persuasion is thought to be less strong.  
While appreciable differences exist between the models (see especially, Eagly & 
Chaiken, 1993, Chapter 7), the purpose and scope of this project does not necessitate 
delving into those differences.   
Two of the most commonly studied variables in this line of research are source 
credibility and argument strength.  Evidence of having relied on source credibility to 
make a decision is often thought to indicate a message receiver is processing the message 
peripherally, relying on the credibility of the source as a cue that they should follow the 
recommendation; evidence of having assessed argument strength is thought to indicate a 
message receiver is processing the message centrally, carefully scrutinizing the content 
(Stiff & Mongeau, 2003).  These dual-process theories are, by no doubt, impressive 
models with extensive research to support these claims.  However, as noted by Stiff and 
Mongeau (2003), tests of models like the ELM rely on the same experimental procedure 
over and over again: 
The procedure involves creating two persuasive messages that advocate the same 
position…one message contains strong arguments supporting the message 
recommendation and the other contains weak arguments.  These messages are 
attributed to a highly or less expert source as they are presented to research 
participants.  (p. 220) 
It is in this between-subjects research design that these theories have fallen short time and 
again to have higher ecological validity.  They fail to take into account the effect of more 
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than one message on an individual’s decision to enact a behavior (i.e., be persuaded to 
vaccinate or not vaccinate). While it is certainly understandable that this research design 
is allows for a high degree of control in an experimental test, it fails to consider the 
processing of more than one persuasive message about a topic.  In other words, what we 
don’t quite know is what role variables like source credibility and argument strength play 
when an individual encounters different messages from more than one source as happens 
in the real world.  Study 2 is designed to address this gap. 
 Related, the tenets of the MCF (e.g., convergent messages from two different 
sources are more persuasive than divergent messages from two different sources) have 
not been empirically tested.  As noted earlier in Study 1, this research project is the first 
time the MCF has been applied to the health communication setting.  What little research 
has been done using the MCF in risk and crisis communication has also suffered from 
methodological limitations from a reliance on the case study.  As noted by Sellnow and 
colleagues (2009),  
The case study approach works well to identify best practices for risk 
communication because individual situations are defined or isolated, relevant data 
are collected about the situation, and the findings are presented in such a way that 
a more complete understanding is reached regarding how messages shape 
perceptions and serve to prompt particular responses from those hearing the 
messages. (p. 53) 
Many sources of data can be used in a case study, such as mass media messages, 
interviews with key stakeholders, and news coverage.  The use of case studies is limiting, 
though, and while it may be appropriate to study temporal events such as a time of crisis 
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and gain knowledge about best practices for similar future situations, this theory can 
benefit from rigorous testing and application.   
As every young social scientist learns, a defining characteristic of a strong social 
scientific theory is that it must be falsifiable or testable in nature (Griffin, 2006; 
Shoemaker, Tankard, & Lasorsa, 2004).  Although to date, the MCF has not benefited 
from empirical tests, whether in risk or health communication, it is a testable framework.  
This current limitation of MCF, combined with Stiff and Mongeau’s (2003) critique of 
the traditional experimental design used in most ELM-type studies, leads to the proposed 
design in the current study: an experimental test of MCF in which there are messages 
from more than one source that may vary on source credibility and argument strength, but 
in which the true “manipulation” comes from exposing individuals to different 
combinations of messages, not just message variables.  In the following sections, I 
separately define source credibility and argument strength and their role in the persuasion 
process, and I pose several research questions and hypotheses relevant to the current 
study.  After examining each variable separately, I return to a discussion of the MCF and 
the effect of multiple messages on message processing and persuasion, and I pose the 
final research question and hypothesis addressing the first experimental test of the MCF.   
Source credibility. While sources may vary or differ on any number of 
characteristics, one of the most powerful source factors in persuasion is source 
credibility.  Especially in the case of recommendations about a health behavior (in this 
case, having an injection), source credibility may serve as an important cue for 
individuals.  In other words, if someone you think is credible tells you to do something 
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(or not do something), then you are more likely to listen to that person than if you heard 
the same message from a less credible person. 
O’Keefe (2002) defines source credibility in the following way: “Credibility (or, 
more carefully expressed, perceived credibility) consists of the judgments made by a 
perceiver (e.g., message recipient) concerning the believability of a communicator” (p.  
181).  Perloff (2010) explains that source credibility is made up of three characteristics or 
qualities: competence is defined as the perceived knowledge or abilities of the 
communicator, caring is defined as the perceived goodwill of the communicator toward 
the audience, and trustworthiness is defined as the perceived honesty or character of the 
communicator.   
For a variety of studies in communication, including health communication, 
higher source credibility consistently predicts attitude change and behavior change in the 
desired direction (Pornpitakpan, 2004).  On the basis of the formative work done in Study 
1 of this project, two sources emerged as the most prevalent in a young women’s 
communication environment about HPV vaccination: mothers and healthcare providers.  
However, it was unclear how credible participants perceived these sources to be in the 
context of HPV vaccination.  In Study 2, which is described in more detail in the next 
chapter, participants will read messages from both a mother figure and a doctor; each of 
these sources will provide a recommendation in their message with regard to HPV 
vaccination.  Based on previous research which says that sources perceived as more 
credible will be more persuasive, the following research hypothesis is posed:  
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Hypothesis 1:  Participants will be more likely to follow the recommendation 
given by sources they perceive as higher in competence/caring/trustworthiness 
than sources they perceive as lower in competence/caring/trustworthiness.   
In addition to the overall effect of source credibility on persuasion, an 
understanding of what type of perceived source credibility (competence, caring, 
trustworthiness) has the largest persuasive impact unclear.  What is clear is that both 
O’Keefe and Perloff emphasize in their writings that source credibility is not so much 
about the communicator as it is about the message receiver’s perception of the 
communicator within a certain context.  In fact, Perloff (2010) notes that “the role a 
communicator plays…can determine the particular aspect of credibility that is most 
important” (p.  169).  While it would seem that medical competence of a trained 
healthcare provider would be the most influential factor in recommendations about a 
vaccine, Study 1 revealed that mothers also played an influential role.  Also, recall that 
for all of the women in Study 1, none of them had decided to get vaccinated.  Therefore, 
because it is unclear which type of source credibility may have the largest impact in the 
context of HPV vaccination, the following research question is posed:  
Research Question 1: Which type of source credibility (i.e., competence, caring, 
trustworthiness) best predicts participants’ likelihood to follow the source’s 
recommendation? 
Finally, given that this study privileges the role that multiple messages from 
multiple sources over time has on an individual’s health behavior, it would be negligent 
to ignore the role that past communication with sources has on an individual’s perception 
of similar sources in this study.  While it is not possible to control for and account for all 
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HPV vaccination messages from past sources within Study 2, it is possible to measure 
past communication with the two sources that emerged as the most influential in Study 1: 
mothers and healthcare providers.   Therefore, the following research question is posed:  
Research Question 2:  What effect does past conversation with a source have on 
participant’s perceptions of that source’s credibility (i.e., competence, caring, 
trustworthiness)? 
Argument strength.  What do advertisers, politicians, cult leaders and health 
behavior change researchers all have in common?  When presenting individuals with a 
persuasive message, they hope it is perceived as a strong argument.  Zhao, Strasser, 
Cappella, Lerman, and Fishbein (2011) define perceived argument strength as “audience 
members’ perceptions of the quality, strength, and persuasiveness of the arguments 
employed in a persuasive communication” (p. 50).  Several researchers note that 
argument strength is one of the most manipulated and studied message variables in 
persuasion research, and all suggest that a message perceived as stronger will be more 
persuasive (Johnson, Maio, & Smith-McLallen, 2005; Johnson, Smith-McLallen, Killeya, 
& Levin, 2004; Petty & Cacioppo, 1986; Petty, Kasmer, Haugtvedt, & Cacioppo, 1987).   
Because of this focused attention, as is the case in many commonly studied social 
science variables, there are many different measures of argument strength (Bassili, 1996).  
In reviewing those past measures and identifying the limitations, Zhao et al. (2011) 
developed a new measure that accounted for a more robust assessment of perceived 
argument strength.  For example, they included items in their scale that addressed not 
only likelihood of agreement or favorability toward an argument, which is consistent with 
the dominant measure of argument strength through a thought listing technique, but also 
!
57 
items that addressed perceived truth value, perceived importance, perceived confidence in 
the argument’s recommendation, and a summative measure assessing individuals’ 
perceptions of the argument quality.  
Unfortunately, the use of this more robust measure in research suffers from two 
limitations.  First, most likely due to the scale developers own desire to use their scale 
once it was published, many of those same individuals have used the scale in their own 
research that centers on one behavior – smoking (Bigsby, Cappella, & Seitz, 2012; 
Falcone et al., 2011; Lee & Cappella, 2013; Lee, Cappella, Lerman, & Strasser, 2011, 
2013).  In addition, many of these published smoking studies appear to come from the 
same large dataset, suggesting the scale has not been tested in truly different contexts.   
Second, for this series of studies, the scale was used as a manipulation check for 
argument strength manipulations for created messages.  While this is arguably a positive 
use of the scale, it fails to consider the perceived argument strength of existing persuasive 
communications.   
In this research project, the persuasiveness of existing messages in the 
communication environment is the focus.  Therefore, given previous research that 
suggests arguments perceived as stronger are more persuasive and given the formative 
work done in Study 1 that suggests some young women may be likely to follow 
recommendations about HPV vaccination without the preexisting attitudes and beliefs 
that are thought to drive behavior, the following research hypothesis is posed:  
Hypothesis 2: Messages perceived as having a stronger argument (i.e., type of 
risk) will be positively related to participants’ likelihood to follow the message 
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recommendation (i.e., vaccinate, not vaccinate) more than arguments perceived as 
weak. 
Message convergence framework.  Finally, in returning to the theoretical 
framework of this research project, the MCF informs the main hypotheses and research 
questions for Study 2.  Recall from Chapter 2 that Sellnow et al. (2009) claim that “when 
distinct bodies of knowledge overlap, resulting in some capacity of agreement” (p. 12), 
there is message convergence.  In instances of a high degree of message convergence, 
individuals can feel more certain about the messages they hear and the recommendations 
contained within those messages.  Hence, an individual would be more likely to follow 
the consonant recommendation.  Alternatively, in cases of message divergence, 
individuals must evaluate the claims in those messages and make choices about whom to 
believe and which recommendation to follow.   
The findings from Study 1 indicate that mothers and healthcare providers played 
the largest role in young women’s HPV vaccination communication environment and 
participants most often discussed the interaction of messages from these two sources (i.e., 
my doctor was saying this, but my mom was saying this).  Additionally, Study 1 findings 
revealed that mothers often voiced messages about the risk of the vaccine and 
recommended against vaccination and healthcare providers often voiced messages about 
the risk of cervical cancer and recommended vaccination.  Findings also revealed that 
both sources voiced messages about the lack of risk due to a young woman’s sexual 
naivety and in these cases, both mothers and healthcare providers recommended against 
vaccination.   
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In designing Study 2, I used these findings from Study 1 to enhance external 
validity by using these two sources in an experiment in which young adult females 
receive messages from both sources.  Study 2 uses these two sources (i.e., mother, 
healthcare provider) and each source delivers messages within the same condition (rather 
than having some participants read a message by one source and other participants read a 
messages by another source).  Additionally, these sources will deliver messages that 
converge (agree) or diverge (disagree) on two message content variables, as informed by 
Study 1: type of risk message (i.e., risk of the vaccine, risk of cervical cancer, no risk of 
HPV because woman is sexually naïve) and recommendation for vaccination (i.e., receive 
vaccine, do not receive vaccine).   By asking women to read messages that vary on source 
and content about HPV vaccination, we can extend the MCF by testing messages against 
each other and determining which message combination is the most influential.  
However, for the purpose of analyses and because the most likely focus of a future 
intervention would be with a healthcare provider, the following hypothesis is set up to 
test the likelihood of participants following the doctor’s recommendation.  As such, the 
hypothesis reads:  
Hypothesis 3: Participants who receive messages from doctors and mothers that 
converge on both recommendation and risk (i.e., Conditions 1, 5, 9) will be more 
likely to follow the recommendation given by the doctor than participants who 
receive messages from both sources with mixed message characteristics 
(divergence on risk and convergence on recommendation; i.e., Conditions 7, 3) or 
participants who receive messages from mothers and doctors that diverge on both 
recommendation and risk (i.e., Conditions 2, 4, 6, 8).  
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Finally, in keeping with the idea that the MCF considers the communication 
environment around an issue over time (i.e., a movie reel) and not just one or two 
messages at one time point (i.e., a snapshot), this study considers the effect of past 
messages about HPV vaccination and their effect on current message processing.  While 
an analysis of all previous HPV vaccination messages from all sources is not within the 
scope of the current project, it is feasible in the current study to measure the effect of 
previous conversations about HPV vaccination with one of the two target sources (i.e., 
mother and doctor) on a young woman’s likelihood to follow the recommendation of the 
doctor.  Hence, the final research question for Study 2 is: 
Research Question 3: What is the effect, if any, of past conversations with a 
mother/mother figure or doctor on participants’ likelihood to follow the doctor’s 
recommendation? 
In sum, Study 2 is proposed as an experiment to test these common message 
sources and message content variables to determine what may be the most influential 
source/message combination.  Rather than the common source vs. message factorial 
design discussed at the beginning of this chapter, Study 2 adheres to the MCF and uses a 
source/message vs. source/message design to uncover how these elements affect a 
woman’s decision to vaccinate.  Study 2 methods and results are detailed in the next 
chapter. 
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CHAPTER 5 
Study 2 
Building on the findings from Study 1 and in an effort to provide an empirical test of the 
message convergence framework, Study 2 is an experiment in which participants are 
randomly assigned to read messages from two difference sources (mother, healthcare 
provider), that convergence, diverge or have mixed message characteristics with regard to 
type of risk message and type of recommendation.  As noted previously, work in HPV 
vaccination promotion, specifically, and previous health persuasion research, generally, 
have for the most part fallen short in empirically examining how individuals process 
persuasive communications from more than one source at the same time.  Study 2, 
outlined in this chapter, addresses this gap. 
Method 
Participants and Recruitment 
 Participants in this study were 309 unvaccinated women ranging in age from 18 to 
30 years old (M = 19.58, SD = 1.99).  The university institutional review board approved 
all procedures prior to study initiation.  Given the 3 X 3 modified factorial design 
(described below) and the desired minimum of 30 participants per cell for adequate 
power (Cohen, 1988; VanVoorhis & Morgan, 2007) resulted in a desired sample size of 
at least 270 participants.  Recruitment of participants continued until this number was 
reached and slightly exceeded for the experimental survey.   
Participants were recruited in two ways.  First, female students enrolled in lower-
division communication courses were notified about this study through the Department of 
Communication’s research participant pool which includes more than 3,500 students 
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enrolled in general education courses from a variety of majors across the university.  
Students who are a part of this research participant pool are required to complete a 
research study as part of course requirements. The following study information (Table 
5.1) was posted to all students on an electronic bulletin board:   
Table 5.1 
Study Recruitment Information 
Study Information 
Study Name Communication About Women's Health 
Abstract Quick online survey about HPV vaccine and Cervical Cancer 
Description This study is a quick (no more than 15-20 minutes) survey that you can 
complete at home on your own computer. We want to know your 
perspectives on the HPV vaccine and cervical cancer prevention so 
that we can design better health messages about these topics. 
Web Study This is an online study. Participants are not given the study URL until 
after they sign up. 
Eligibility 
Requirements 
Female; between 18-30 years old; has not received the HPV vaccine 
Duration 20 minutes  
Credits 1 Credits 
 
Students who desired to participate in the study and met the eligibility 
requirements enrolled in the study. A total of 279 participants were recruited through this 
method.  Second, women were recruited from the general campus population through 
fliers posted around campus and in some sorority houses; the fliers contained the same 
information listed in the SONA post above with the exception of the incentive offer of an 
online $10 Target gift card or an online $10 Starbucks gift card. The flier prompted 
eligible participants to email the principal researcher to complete the study. A total of 30 
participants was recruited through this second recruitment method.   
Although there were some significant differences between the two groups of 
participants on demographic variables (see Table 5.2), there were no significant 
!
63 
differences on any of the outcome variables (discussed below).   Therefore, these two 
groups are considered one sample from this point forward.   
Table 5.2 
Participant Characteristics 
 Combined Total SONA 
Research 
Participants 
General Campus 
Population 
Difference 
Age 19.58 (SD=1.99) 19.35 
(SD=1.91) 
21.53 (SD=1.53) t = -6.06 (p <.001) 
     
College 
Classification 
   X2 = 110.74 (p < .001) 
Freshman 53.4% (n = 165) 59.8% (n = 168) 0% (n = 0)  
Sophomore 16.5% (n = 51) 17.8% (n = 50) 3.2% (n = 1)  
Junior 19.4%(n = 60) 16.4% (n = 46) 45.2% (n = 14)  
Senior 8.7% (n = 27) 6.0% (n = 17) 32.3% (n = 10)  
Graduate Student 0.6% (n = 2) 0% (n = 0) 6.5% (n = 2)  
N/A 
 
1.0% (n = 4) 0% (n = 0) 12.9% (n = 4)  
Race     
White/Caucasian 82.8% (n = 256)a 81.1% (n = 228) 90.3% (n = 28) X2 = 1.60 (p = .21) 
African American 10.7% (n = 33) 11.4% (n = 32) 3.2% (n = 1) X2 = 1.97 (p = .16) 
Hispanic 2.9% (n = 9) 2.5% (n = 7) 6.5% (n = 2) X2 = 1.56 (p = .21) 
Asian 5.2% (n = 16) 5.3% (n = 15) 3.2% (n = 1) X2 = 0.27 (p = .61) 
Native American 1.0% (n = 3) 1.1% (n = 3) 0% (n = 0) X2 = 0.33 (p = .56) 
Pacific Islander 0.6% (n = 2) 0.7% (n = 2) 0% (n = 0) X2 = 0.22 (p = .64) 
Other 3.6% (n = 11) 3.9% (n = 11) 0% (n = 0) X2 = 1.26 (p = .26) 
Note. a Participants were allowed to provide multiple answers for race; therefore, each 
race category is treated as a separate variable and separate chi-square tests were run to 
test for differences. 
Procedures 
 
 Eligible participants who signed up for the research study were directed by either 
email or the student research participant pool system to an Internet survey to complete the 
study. All participants read an IRB-approved consent form on the opening webpage and 
were instructed that by clicking the “continue with survey” button at the bottom of the 
!
64 
page, they were giving implied consent to participate in the study. A copy of the consent 
form can be found in Appendix A. 
As a safety measure to ensure that only eligible participants completed the 
experimental section of the Internet study, participants were prevented from completing 
the study if they answered “male” to the gender question or answered “18 or younger” or 
“31 or older” to the age question; instead, they were directed to a page that informed 
them of their ineligibility for this study and thanked them for their time.  However, 
despite the requirement that participants be unvaccinated, if they answered “Yes” to 
receiving the HPV vaccine, they were allowed to complete a short survey about past HPV 
vaccination behaviors (see Appendix B for list of questions). They were then directed to 
the end of the survey where they filled out their information and were given credit for 
completing the study.   
There was a specific reason that these vaccinated women were allowed to 
complete a portion of the survey.  Some women might have honestly believed they met 
the general eligibility requirement of being “unvaccinated” if they had only received 
doses 1 or 2 of the 3-part HPV vaccine series.  In other words, if a woman had only 
received doses 1 or 2, she might believe she is eligible to complete a study about not 
having the HPV vaccine (since she didn’t complete the three-dose regimen).  Seventy-
one participants (68 participants recruited through the research participant pool and three 
participants recruited through the general student population) completed the modified, 
shorter version of the survey as partially vaccinated participants.  However, because the 
objective of the study was to examine truly unvaccinated women and their responses to 
the message manipulations, and because these partially vaccinated women did not 
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complete the experiment portion of the study, this group of participants is not mentioned 
again. 
 Truly unvaccinated women completed the entire experimental survey.  The 
survey began with demographic questions, questions regarding attitudes and beliefs about 
the HPV vaccine, questions regarding past conversations about HPV vaccination, and 
questions about behavioral intent to receive the HPV vaccine.  Next, participants were 
randomly assigned by the Qualtrics Internet survey software to one of nine message 
conditions.   Finally, participants completed post-test measures including perceptions of 
source credibility, perceptions of argument strength, and questions about behavioral 
intent to receive the HPV vaccine.  (All measures and the messages are described in 
detail in the following sections.)  After completing the Internet survey, all participants 
were thanked for their time and were presented with a debriefing page including 
information about the HPV vaccine (CDC, 2011) and information about the HPV 
vaccine’s availability in the Lexington area.  Finally, students eligible for the study 
incentive were directed to a second “survey” asking them to enter their first name, last 
name, email address, and their preference for a $10 Target gift card or a $10 Starbucks 
gift card.   Participants recruited through the student research participant pool were asked 
to enter their first name, last name, and student ID in order to receive credit for 
participating. All participants were assured that their personal information would not be 
associated with their responses in the survey and the information was solely gathered in 
order to deliver their gift card or course credit, respectively. 
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Message Manipulations 
 
 There were nine message manipulations for the experiment embedded in the 
Qualtrics Internet survey. As noted earlier, the Qualtrics program randomly assigned 
participants to one message condition and then directed participants to the post-test 
measures.  When participants reached the message stimuli section of the Internet survey, 
they first read a prompt that set up a story about a young woman named Sarah who was 
thinking about getting the HPV vaccine.  The prompt read: 
Now, we want you to read a story about a young woman who is 
deciding whether to get the HPV vaccine.  She hears information about 
the vaccine from a couple of different sources, which may influence her 
decision.  Please read Sarah's story and respond to the questions.  
Sarah is a 20 year old sophomore at the University of 
Kentucky.  She has had sex a couple of times while in college, although 
she has not told her mother or doctor that she is sexually active. 
She is trying to decide whether she should get the HPV 
vaccine.  She knows that HPV is a common sexually transmitted disease 
among college-aged women.  She also knows that a vaccine is available 
to protect against the types of HPV known to cause cervical cancer. 
Sarah hears messages about the HPV vaccine from both her 
doctor and her mother.   
 After reading this prompt, participants were instructed to click “Next” (and 
randomly assigned to one of the message conditions) to read the messages from the 
doctor and mother. Message conditions varied on type of message received from mother 
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source (short-term risk of HPV vaccination, long-term risk of cervical cancer, or no risk 
of HPV infection) and type of message received from doctor source (short-term risk of 
HPV vaccination, long-term risk of cervical cancer, or no risk of HPV infection).  To 
clarify, participants received a message from both the mother and doctor source; to 
control for order effects, participants were randomly assigned to receive the mother or 
doctor message first.  As a secondary check of order effects, a series of t-tests were run to 
determine if there were any significant differences on the major experimental variables of 
interest in the study (i.e., those measured in the posttest: perceptions of source credibility, 
perceptions of argument strength and the likelihood to follow recommendation outcome 
variables).  No significant differences were found for any of these variables between 
groups that read the mother message first or groups that read the doctor message first. 
Table 5.3 provides information on the content of the messages; the choice of sources and 
the content of the messages in this experiment were informed by the formative research 
conducted in Study 1. 
Table 5.3 
Experiment Messages 
Message Type Content of Message 
Argument Recommendation  
Short-term Risk You may experience side effects from the 
vaccine like a fever or rash, especially 
because it is new.   
 
I don’t think you 
should get the vaccine. 
Long-term Risk There is the risk of you getting HPV and 
it turning into cervical cancer later in 
life.  
 
I think you should get 
the vaccine. 
No Risk You aren’t sexually active, so there is no 
risk of you getting HPV in the first place.   
 
I don’t think you 
should get the vaccine. 
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The created message conditions resulted in a 3 x 3 design, presented below in 
Table 5.4.   Each condition is numbered to facilitate discussion.  As is described later, 
message conditions 1, 5, and 9 converge on risk and recommendation; message 
conditions 3 and 7 diverge on risk but converge on recommendation; and message 
conditions 2, 4, 6, and 8 diverge on risk and recommendation. 
 Table 5.4 
Factorial Design 
  Healthcare Provider 
  Short-term Risk Long-term Risk No Risk 
Mother Short-term Risk 1 2 3 
Long-term Risk 4 5 6 
No Risk 7 8 9 
 
Measures  
 
 The survey for this study can be found in Appendix B; however, only items 
relevant to the main dissertation study and that address the hypotheses and research 
questions described in Chapter 4 are presented in detail here.  These items are basic 
demographics (presented in the “Participants and Recruitment” section above), the 
control variables of past conversations about HPV vaccination with both mother/mother 
figures and healthcare providers, independent variables of interest (including the stimuli-
related measures of perceived source credibility and perceived argument strength), and 
outcome variables including behavioral intention to receive the HPV vaccine.  In 
addition, several computed variables are discussed below, such as the type of past 
conversations about HPV vaccination with mother/mother figures and healthcare 
providers, type of message stimuli convergence, and likelihood to follow the message 
recommendation with regard to HPV vaccination receipt. 
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Past Conversations.  Participants’ past conversations about HPV vaccination 
with their mothers/mother figures and healthcare providers were measured.  This measure 
included two parts.  First, each participant was asked if she had ever discussed HPV 
vaccination with the two sources of interest in this study (have you ever discussed HPV 
vaccination with a healthcare provider? have you ever discussed HPV vaccination with 
your mom or a mother figure in your life?); the response items for these questions were 
(a) yes or (b) no.   If a participant answered yes, she was then asked to indicate what that 
source advised her to do (did the provider (a) recommend that you receive the HPV 
vaccine or (b) recommend that you not receive the HPV vaccine?; did your mom (or 
mother figure) (a) recommend that you receive the HPV vaccine or (b) recommend that 
you not receive the HPV vaccine?).  Descriptive statistics for this variable are presented 
in Table 5.5 below.  
Table 5.5  
Past HPV Vaccination Conversations 
 Percent Frequency 
Self-Reported Past Conversation with Mother   
No 40.1% n = 125 
Yes 58.7% n = 183 
Recommended vaccination 59.6% n = 109 
Did not recommend vaccination 40.4% n =  74 
   
Self-Reported Past Conversation with Doctor   
No 48.1% n = 150 
Yes 51.0% n = 159 
Recommended vaccination 89.3% n = 142 
Did not recommend vaccination 10.1% n =  16 
 
For the purpose of analysis, two ordinal variables representing the nature of past 
conversations were created: one for past conversation with a participant’s mother/mother 
figure and one for past conversations with a healthcare provider.  Participants who 
reported no past conversations were given the value of 0, participants who reported past 
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conversations with a recommendation to not receive the HPV vaccine were given the 
value of -1, and participants who reported past conversations with a recommendation to 
receive the HPV vaccine were given the value of +1.  Therefore, every participant had 
two past conversation scores, one that reflected the nature of her conversations with her 
mother/mother figure and one that reflected the nature of her conversations with her 
healthcare provider. 
Source Credibility.  Each participant’s perception of source credibility was 
measured using a seven-point semantic differential scale (McCroskey & Teven, 1999).  
Source credibility is composed of three separate subscales and each subscale has its own 
set of items: competence ( intelligent/unintelligent, untrained/trained, inexpert/expert, 
informed/uninformed, incompetent/competent, and bright/stupid); caring (cares about 
me/doesn't care about me, has my interests at heart/doesn't have my interests at heart, 
self-centered/not self-centered, concerned with me/not concerned with me, 
insensitive/sensitive, and not understanding/understanding); and trustworthiness 
(honest/dishonest, untrustworthy/trustworthy, honorable/dishonorable, moral/immoral, 
unethical/ethical, and phony/genuine).  Because each participant read messages from both 
a mother source and a doctor source, each participant answered these questions twice. 
Scores on the three separate subscales are presented separately for each source below.  
Included in these sections are descriptions of dichotomizing each subscale into high and 
low values using a median split (MacCallum, Zhang, Preacher, & Rucker, 2002).  
Detailed descriptive statistics (including scores on each credibility scale for each 
condition) are presented in Table 5.6 for the mother source and Table 5.7 for the doctor 
source.   
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Mother competence.  Exploratory factor analysis (principal components) revealed 
a unidimensional solution to the mother competence subscale.  The six competence items 
were averaged (M = 3.91, SD = 1.25) to compute a reliable (! = 0.84) perceived mother 
competence scale, where higher scores indicate that participants perceived the mother 
source to be more competent.   Using a median split (Md = 3.83), scores on the perceived 
mother competence scale were dichotomized into a new variable; participants who rated 
the mother’s competence at or below 3.83 were labeled as perceived low mother 
competence and participants who rated the mother’s competence above 3.83 were labeled 
as perceived high mother competence. 
Mother caring.  Exploratory factor analysis (principal components) revealed a 
unidimensional solution to the mother caring scale.  The six caring items were averaged 
(M = 5.23, SD = 1.26) to compute a reliable (! = 0.85) perceived mother caring scale, 
where higher scores indicate that participants perceived the mother source to be more 
caring.  Using a median split (Md = 5.33), scores on the perceived mother caring scale 
were dichotomized into a new variable; participants who rated the mother’s caring at or 
below 5.33 were labeled as perceived low mother caring and participants who rated the 
mother’s caring above 5.33 were labeled as perceived high mother caring. 
Mother trustworthiness. Exploratory factor analysis (principal components) 
revealed a unidimensional solution to the mother trustworthiness scale.  The six 
trustworthiness items were averaged (M = 5.18, SD = 1.18) to compute a reliable (! = 
0.89) perceived mother trustworthiness scale, where higher scores indicate that 
participants perceived the mother source to be more trustworthy.  Using a median split 
(Md = 5.17), scores on the perceived mother trustworthiness scale were dichotomized 
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into a new variable; participants who rated the mother’s trustworthiness at or below 5.17 
were labeled as perceived low mother trustworthiness and participants who rated the 
mother’s trustworthiness above 5.17 were labeled perceived high mother trustworthiness.  
Doctor competence.  Exploratory factor analysis (principal components) revealed 
a unidimensional solution to the doctor competence scale.  The six competence items 
were averaged (M = 5.45, SD = 1.47) to compute a reliable (! = 0.92) perceived doctor 
competence scale, where higher scores indicate that participants perceived the doctor 
source to be more competent.  Using a median split (Md = 5.83), scores on the perceived 
doctor competence scale were dichotomized into a new variable; participants who rated 
the doctor’s competence at or below 5.83 were labeled as perceived low doctor 
competence and participants who rated the doctor’s competence above 5.83 were labeled 
as perceived high doctor competence. 
Doctor caring.  Exploratory factor analysis (principal components) revealed a 
unidimensional solution to the doctor caring scale.  The six caring items were averaged 
(M = 4.86, SD = 1.23) to compute a reliable (! = 0.88) perceived doctor caring scale, 
where higher scores indicate that participants perceived the doctor source to be more 
caring.  Using a median split (Md = 4.83), scores on the perceived doctor caring scale 
were dichotomized into a new variable; participants who rated the doctor’s caring at or 
below 4.83 were labeled as perceived low doctor caring and participants who rated the 
doctor’s caring above 4.83 were labeled as perceived high doctor caring. 
Doctor trustworthiness.  Exploratory factor analysis (principal components) 
revealed a unidimensional solution to the doctor trustworthiness scale.  The six 
trustworthiness items were averaged (M = 5.23, SD = 1.24) to compute a reliable (! = 
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0.92) perceived doctor trustworthiness scale, where higher scores indicate that 
participants perceived the doctor source to be more trustworthy.  Using a median split 
(Md = 5.17), scores on the perceived doctor trustworthiness scale were dichotomized into 
a new variable; participants who rated the doctor’s trustworthiness at or below 5.17 were 
labeled as perceived low doctor trustworthiness and participants who rated the doctor’s 
trustworthiness above 5.17 were labeled as perceived high doctor trustworthiness. 
Table 5.6 
Mother Source Credibility Descriptive Statistics 
Type of  
Credibility 
Condition Reliability  
(!) 
Mean  
Score  
(M) 
Standard   
Deviation  
(SD) 
Perceived 
Mother 
Competence 
Overall – All Conditions .84 3.91 1.25 
Mom Short-term Risk .87 3.60 1.21 
Condition  1   3.80 1.22 
2   3.27 1.17 
3   3.74 1.20 
Mom Long-term Risk .89 4.81 1.09 
4  4.69 .94 
5  4.84 1.10 
6  4.92 1.25 
Mom Lack of Risk (No Sex) .75 3.32 .88 
7  3.49 .88 
8  3.18 .90 
9  3.29 .86 
Perceived 
Mother 
Caring 
Overall – All Conditions .85 5.23 1.26 
Mom Short-term Risk .89 5.02 1.24 
Condition  1  4.91 1.34 
2  4.94 1.23 
3  5.21 1.16 
Mom Long-term Risk .80 6.11 .78 
4  6.08 .74 
5  6.16 .75 
6  6.12 .87 
Mom Lack of Risk (No Sex) .86 4.55 1.17 
7  4.77 1.01 
8  4.42 1.44 
9  4.47 1.00 
!
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Table 5.6 (continued) 
Perceived 
Mother 
Trustworthiness 
Overall – All Conditions .89 5.18 1.18 
Mom Short-term Risk .92 4.90 1.17 
Condition 1  4.93 1.22 
2  4.83 1.15 
3  4.94 1.16 
Mom Long-term Risk .91 5.92 .94 
4  5.83 .89 
5  5.95 .93 
6  5.97 1.02 
Mom Lack of Risk (No Sex) .85 4.73 1.05 
7  4.98 .91 
8  4.73 1.12 
9  4.50 1.07 
 
Table 5.7 
Doctor Source Credibility Descriptive Statistics 
Type of  
Credibility 
Condition Reliability  
(!) 
Mean  
Score  
(M) 
Standard   
Deviation  
(SD) 
Perceived 
Doctor 
Competence 
Overall – All Conditions .92 5.45 1.47 
Doctor Short-term Risk .94 5.23 1.50 
     Condition  1   5.22 1.56 
4   5.33 1.61 
7  5.14 1.36 
Doctor Long-term Risk .92 6.30 .96 
2  6.27 .97 
5  6.28 1.10 
8  6.37 .80 
Doctor Lack of Risk (No Sex) .90 4.81 1.46 
3  5.01 1.40 
6  5.14 1.58 
9  4.29 1.29 
Perceived 
Doctor 
Caring 
Overall – All Conditions .88 4.86 1.23 
Doctor Short-term Risk .89 4.71 1.20 
Condition 1   4.70 1.41 
4   4.76 1.18 
7  4.68 .99 
Doctor Long-term Risk .88 5.41 1.11 
2  5.31 1.15 
5  5.33 1.08 
8  5.59 1.11 
!
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Table 5.7 (continued) 
 Doctor Lack of Risk (No Sex) .86 4.45 1.19 
3  4.65 1.20 
6  4.63 1.29 
9  4.07 .98 
Perceived 
Doctor 
Trustworthiness 
Overall – All Conditions .92 5.23 1.24 
Doctor Short-term Risk .94 5.01 1.28 
Condition 1   5.02 1.44 
4   5.05 1.17 
7  4.95 1.25 
Doctor Long-term Risk .92 5.84 1.00 
2  5.68 1.02 
5  5.96 .90 
8  5.90 1.07 
Doctor Lack of Risk (No Sex) .91 4.83 1.20 
3  4.96 1.22 
6  5.13 1.36 
9  4.41 .92 
 
Argument Strength. A modified version of the perceived argument strength 
scale developed by Zhao et al. (2011) was used to identify participants’ perceptions of the 
message argument strength.  The scale contains two parts.  First, participants responded 
to five statements/questions about the target argument using a four-point Likert type scale 
where 1 = strongly disagree and 4 = strongly agree; items included the following: (a) the 
statement is a reason for ___ that is believable, (b) the statement is a reason for ___ that 
is convincing, (c) the statement gives a reason for ___ that is important to me, (d) the 
statement put thoughts in my mind about wanting/not wanting to___, and (e) overall, how 
much do you agree or disagree with the statement?  Second, participants responded to the 
following question using a four-point Likert-type scale where 1 = very weak and 4 = very 
strong: Is the reason the statement gave for ____ a strong or weak reason?  Scores are 
averaged to calculate an overall perceived argument strength score. 
Before presenting the descriptive analysis for this scale, three important points are 
worth making.  First, participants responded using this scale twice, once in reference to 
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the mother message they read and once in reference to the doctor message they read.  
Therefore, each participant has a perceived mother argument strength score and a 
perceived doctor argument strength score. (Note that to ensure participants were 
responding to the correct argument, the specific message [e.g., the mother message] was 
listed at the top of the page as participants answered the questions in this scale.)   Second, 
because participants were randomly assigned to one of three different messages from 
each source, only one-third of participants (n=103) responded to each different message.  
In other words, 103 participants read the mother’s short-term risk message, 103 
participants read the mother’s long-term risk message, and 103 participants read the 
mother’s no risk message.  This was also the case for the doctor messages.  Regardless of 
the message read, a higher score indicates a participant believed the message contained a 
stronger argument, and therefore these different versions of the scale are comparable.  
However, because the arguments were part of the experimental manipulation and were 
completed by different individuals randomly assigned to that message condition, scores 
are left separate for each argument type for the purpose of analysis; see the Message 
Manipulations section above to review the content of the arguments. Third, as seen in the 
scale statements/questions above, there are blanks where the researcher must indicate the 
message outcome participants must respond to.  On the basis of message condition (i.e., 
whether the source recommended the HPV vaccination or whether the source 
recommended not getting the HPV vaccination), participants were directed to respond to 
the appropriate message recommendation outcome on the argument strength scale. For 
example, if participants read a message in which the recommended outcome was to not 
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get the HPV vaccine, the first scale item read, “the statement is a reason for not getting 
the HPV vaccine that is believable.”   
In sum, there are six different versions of this scale that were answered in this 
study, but each participant only answered two of them.  Descriptive data analyses for 
these scales are presented below and the information is presented visually in Table 5.8.   
Mother short-term risk message perceptions (n = 103). Exploratory factor 
analysis (principal components) revealed a unidimensional solution to the argument 
strength scale for participants’ perceptions of the short-term risk message delivered by 
the mother source. The six argument strength items were averaged (M = 2.27, SD = 0.62) 
to compute a reliable (! = 0.88) perceived mother short-term risk message argument 
strength scale, where higher scores on the scale indicate that participants perceived the 
mother short-term risk message as a stronger argument.   
Doctor short-term risk message (n = 103). Exploratory factor analysis (principal 
components) revealed a unidimensional solution to the argument strength scale for 
participants’ perceptions of the short-term risk message delivered by the doctor source. 
The six argument strength items were averaged (M = 2.67, SD = 0.79) to compute a 
reliable (! = 0.91) perceived doctor short-term risk message argument strength scale, 
where higher scores on the scale indicate that participants perceived the doctor short-term 
risk message to be a stronger argument.   
Mother long-term risk message (n = 103). Exploratory factor analysis (principal 
components) revealed a unidimensional solution to the argument strength scale for 
participants’ perceptions of the long-term risk message delivered by the mother source. 
The six argument strength items were averaged (M = 3.15, SD = 0.56) to compute a 
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reliable (! = 0.86) perceived mother long-term risk message argument strength scale, 
where higher scores indicate that participants perceived the mother long-term risk 
message to be a stronger argument.   
Doctor long-term risk message (n = 103).  Exploratory factor analysis (principal 
components) revealed a unidimensional solution to the argument strength scale for 
participants’ perceptions of the long-term risk message delivered by the doctor source. 
The six argument strength items were averaged (M = 3.39, SD = 0.55) to compute a 
reliable (! = 0.86) perceived doctor long-term risk message argument strength scale, 
where higher scores indicate that participants perceived the doctor long-term risk 
message to be a stronger argument.   
Mother no risk message (n = 103).  Exploratory factor analysis (principal 
components) revealed a unidimensional solution to the argument strength scale for 
participants’ perceptions of the no risk message delivered by the mother source. The six 
argument strength items were averaged (M = 2.05, SD = 0.70) to compute a reliable (! = 
0.88)  perceived mother no risk message argument strength scale, where higher scores 
indicate that participants perceived the mother no risk message to be a stronger argument.   
Doctor no risk message (n = 103).  Exploratory factor analysis (principal 
components) revealed a unidimensional solution to the argument strength scale for 
participants’ perceptions of the no risk message delivered by the doctor source. The six 
argument strength items were averaged (M = 2.50, SD = 0.81) to compute a reliable (! = 
0.90) perceived doctor no risk message argument strength scale, where higher scores 
indicate that participants perceived the doctor no risk message to be a stronger argument.   
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Table 5.8 
Argument Strength Descriptive Statistics 
Argu-
ment 
Recommen-
dation 
Reliabil-
ity  
(!) 
Condi-
tion 
Mean Score 
(M) 
Standard 
Deviation (SD) 
Mother 
short-
term risk 
Do not vaccinate .88 Overall 2.27 .620 
1 2.36 .633 
2 2.24 .636 
3 2.20 .600 
Doctor 
short-
term risk 
Do not vaccinate .91 Overall 2.67 .79 
1 2.77 .857 
4 2.59 .890 
7 2.67 .610 
Mother 
long-
term risk 
Vaccinate .86 Overall 3.15 .563 
4 3.10 .644 
5 3.17 .481 
6 3.20 .560 
Doctor 
long-
term risk 
Vaccinate .86 Overall 3.39 .546 
2 3.35 .600 
5 3.27 .583 
8 3.54 .420 
Mother 
no risk 
Do not vaccinate .88 Overall 2.05 .697 
7 1.99 .565 
8 2.02 .808 
9 2.13 .700 
Doctor 
no risk 
Do not vaccinate .90 Overall 2.50 .807 
3 2.70 .751 
6 2.47 .850 
9 2.32 .800 
 
Behavioral Intent 
 
Vaccine receipt.  There were two vaccine receipt intent measures that served as 
outcome variables for this study.  First, each participant was asked what she believed the 
character in the story, Sarah, would do regarding HPV vaccination (how likely do you 
think Sarah would be to get the vaccine?).  Second, participants were asked what they 
would do regarding HPV vaccination after reading Sarah’s story (in thinking about what 
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you read today [i.e., the messages from Sarah’s mother and doctor], how likely are you 
to get the vaccine?). For both of these questions, participants responded using a four-
point Likert-type scale where 1 = very unlikely and 4 = very likely.  Higher scores on 
each of these measures indicated that participant believed Sarah/she would be more likely 
to get the vaccine.   
Likelihood to follow the recommendation within the message. Because many 
of the research questions and hypotheses sought to identify the likelihood to follow the 
recommendation offered in the messages (rather than intent to get the vaccine), a 
secondary outcome measure was calculated called likelihood to follow recommendation. 
Each participant answered questions related to her beliefs about how likely Sarah would 
be to get the vaccine and how likely she personally would be to get the vaccine 
(discussed in the “Vaccine receipt” section above).  These variables were recoded into 
four “likelihood to follow recommendation” variables through a multi-step calculation.  
First, each condition was coded for whether the mother source recommended to get or to 
not get the vaccine.  The same was done for each condition regarding the doctor’s 
recommendation.  Next, the message conditions were nominally coded for whether or not 
the source recommended the vaccine. Each message condition in which the mother 
recommended to get the vaccine (conditions 4, 5, and 6) was coded as a 1. Each message 
condition in which the mother recommended not getting the vaccine (conditions 1, 2, 3, 
7, 8, and 9) was coded as a 2.  Similarly, each message condition in which the doctor 
recommended to get the vaccine (conditions 2, 5, and 8) was coded as a 1.  Each message 
condition in which the doctor recommended not getting the vaccine (conditions 1, 3, 4, 6, 
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7 and 9) was coded as a 2.  See Table 5.9 below for the message conditions and type of 
recommendation from each source.  
Table 5.9 
Recommendations by Sources for Each Message Condition 
Condition Mother says… Doctor says… 
Get it Don’t 
get it 
Recommendation 
Score 
Get it Don’t 
get it 
Recommendation 
Score 
1  * 2  * 2 
2  * 2 *  1 
3  * 2  * 2 
4 *  1  * 2 
5 *  1 *  1 
6 *  1  * 2 
7  * 2  * 2 
8  * 2 *  1 
9  * 2  * 2 
 
Recall that participants answered two vaccine receipt intention questions (i.e., 
how likely do you think Sarah would be to get the vaccine? and in thinking about what 
you read today [i.e., the messages from Sarah’s mother and doctor], how likely are you 
to get the vaccine?) and that for both of these questions, participants responded using a 
four-point Likert type scale where 1 = very unlikely and 4 = very likely.  Scores for these 
questions, combined with the recommendation from each source in each message 
condition, were used to calculate four new outcome variables, [Sarah or Participant] 
likelihood to follow [mother’s or doctor’s] recommendation.  For conditions in which the 
mother source recommended to get the vaccine, the values associated with the original 
vaccine receipt intent measure (1 = very unlikely 2 = somewhat unlikely, 3 = somewhat 
likely, and 4 = very likely) were used as the new values for the likelihood to follow 
recommendation variable because following the recommendation to get the vaccine (i.e., 
following the mom’s advice) and being more likely to get the vaccine (i.e., a higher 
score) would be the same.  In other words, for conditions in which the mother 
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recommended getting the vaccine, participants’ scores on the behavioral intent measure 
(likelihood to get the vaccine) were simply copied for the new likelihood to follow 
recommendation outcome variable.  For conditions in which the mother recommended 
not getting the vaccine, the values were recoded into the opposite value (1 = 4, 2 = 3, 3 = 
2, and 4 = 1) because if a participant read a message where the mother source 
recommended to not get the vaccine, yet the participant selected that Sarah/she would be 
very likely to get it, then this would result in the participant’s believing Sarah/she would 
be very unlikely to follow the recommendation.  The data transformation (or, recoding) is 
displayed below in Table 5.10.  This process resulted in four new variables (Sarah’s 
likelihood to follow mother recommendation, Participant’s likelihood to follow mother 
recommendation, Sarah’s likelihood to follow doctor recommendation, and Participant’s 
likelihood to follow doctor recommendation), which served as the primary outcome 
variables for most of the analyses.  
Table 5.10 
Recoding of Likelihood Outcome Variables 
 Recoded into 
Sarah’s/Participant’s 
Likelihood to Get 
Vaccine (Original 
Scores on 
Behavioral Intent 
Measure) 
Sarah’s/Participant’s Likelihood 
to Follow Mother 
Recommendation 
Sarah’s/Participant’s to Follow 
Doctor Recommendation 
Conditions 
Where Mother 
Says Get 
Vaccine 
Conditions 
Where Mother 
Says Not Get 
Vaccine 
Conditions 
Where Doctor 
Says Get 
Vaccine 
Conditions 
Where Doctor 
Says Not Get 
Vaccine 
1 = very unlikely 1 = very 
unlikely 
4 = very 
unlikely  
1 = very 
unlikely 
4 = very 
unlikely  
2 = somewhat 
unlikely 
2 = somewhat 
unlikely 
3 = somewhat 
unlikely  
2 = somewhat 
unlikely 
3 = somewhat 
unlikely  
3 = somewhat likely 3 = somewhat 
likely 
2 = somewhat 
likely 
3 = somewhat 
likely 
2 = somewhat 
likely 
4 = very likely 4 = very likely 1 = very likely 4 = very likely 1 = very likely 
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Finally, for each of the four the new likelihood to follow recommendation 
variables created above, a final dichotomized variable for each likelihood outcome was 
created.  If a participant scored 1 or 2 on the likelihood to follow the recommendation, 
this was recoded into 1 for “not likely.”  If a participant scored a 3 or 4 on the likelihood 
to follow the recommendation, this was recoded into a 2 for “likely.”   
 
Results 
Hypothesis 1 
Hypothesis 1 predicted that participants will more likely follow the 
recommendation given by sources they perceive as higher in 
credibility/caring/trustworthiness than sources they perceive as lower in 
credibility/caring/trustworthiness.  A series of t-tests was run to test this hypothesis.  
Given that there are four different likelihood to follow recommendation variables and 
three different types of source credibility for each source (competence, caring, and 
trustworthiness for both mother and doctor), the total number of t-tests run was 12.  
Results are reported below and in Table 5.11 (for Sarah’s likelihood to follow 
recommendation from both sources) and Table 5.12 (for participant likelihood to follow 
recommendation from both sources). 
Source credibility and Sarah’s likelihood to follow mother’s recommendation. 
Results showed no significant differences for perceived mother competence, t (304) = 
0.80, p = 0.42 (Mlow = 2.86, Mhigh = 2.83) or perceived mother caring, t (304) = 0.46, p = 
0.64 (Mlow = 2.87, Mhigh = 2.83). However, there was a significant difference for 
perceived mother trustworthiness, t (304) = 2.07, p = 0.04 (Mlow = 2.80, Mhigh = 2.89).  
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Therefore, Hypothesis 1 was partially supported for the outcome variable Sarah’s 
likelihood to follow mother’s recommendation.  Participants were more likely to believe 
that Sarah would follow the mother’s recommendation when they perceived the mother 
source to have higher trustworthiness, but they were not more likely to believe that Sarah 
would follow the mother’s recommendation due to perceived higher mother competence 
or mother caring.  In order to better see the distribution of scores, results in Table 5.11 
(and Table 5.12) also present the percentage of participants who chose very unlikely, 
somewhat unlikely, somewhat likely and very likely for likelihood to follow the 
recommendation, situated within the high and low source credibility conditions. 
Source credibility and Sarah’s likelihood to follow doctor’s recommendation.  
Results showed no significant differences for perceived doctor competence, t (303) = 
0.20, p = 0.84 (Mlow = 2.91, Mhigh = 2.85), perceived doctor caring, t (303) = 0.62, p = 
0.54 (Mlow = 2.90, Mhigh = 2.81), or perceived doctor trustworthiness, t (303) = 0.56, p = 
0.57 (Mlow = 2.87, Mhigh = 2.86).  Therefore, Hypothesis 1 was not supported for the 
outcome variable Sarah’s likelihood to follow the doctor’s recommendation.  Participants 
were not more likely to believe that Sarah would follow the doctor’s recommendation 
regardless of how they perceived the doctor’s competence, caring, or trustworthiness. 
Table 5.11 
Hypothesis 1 Results for Source Credibility and Sarah’s Likelihood  
 Sarah’s Likelihood to Follow Recommendation  
 Very 
unlikely 
Somewhat 
unlikely 
Somewhat 
likely 
Very Likely p-value 
Mother % (n)     
Competence      
Low 
M = 2.96 (SD = .69) 
50% (4) 45.9% (45) 40.6% (54) 55.2% (37) .42 
High 
M = 4.95 (SD = .81) 
50% (4) 54.1% (53) 59.4% (79) 44.8% (30)  
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Table 5.11 (continued) 
Caring      
Low 
M = 4.18 (SD = .86) 
50% (4) 54.1% (53) 39.8% (53) 61.2% (41) .64 
High 
M = 6.25 (SD = .56) 
50% (4) 45.9% (45) 60.2% (80) 38.8% (26)  
Trustworthiness      
Low 
M = 4.23 (SD = .71) 
25.0% (2) 39.8% (39) 51.5% (68) 52.2% (35) .04 
High 
M = 6.19 (SD = .58) 
75.0% (6) 60.2% (59) 48.5% (64) 47.8% (32)  
      
Doctor      
Competence      
Low 
M = 4.01 (SD = 1.04) 
33.3% (3) 54.4% (49) 42.9% (60) 54.5% (36) .84 
High  
M = 6.52 (SD = .50) 
66.7% (6) 45.6% (41) 57.1% (80) 45.5% (30)  
Caring      
Low 
M = 3.91 (SD = .71) 
11.1% (1) 53.3% (48) 45.7% (64) 51.5% (34) .54 
High 
M = 5.93 (SD = .69) 
88.9% (8) 46.7% (42) 54.3% (76) 48.5% (32)  
Trustworthiness      
Low 
M = 4.18 (SD = .74) 
22.2% (2) 52.2% (47) 42.9% (60) 53.0% (35) .57 
High 
M = 6.28 (SD = .59) 
77.8% (7) 47.8% (43) 57.1% (80) 47.0% (31)  
 
Source credibility and participant’s likelihood to follow mother’s 
recommendation.  Results showed significant differences for perceived mother 
competence, t (306) = -3.58, p < 0.001 (Mlow = 2.46, Mhigh = 2.84), perceived mother 
caring, t (306) = -2.42, p = 0.02 (Mlow = 2.51, Mhigh = 2.76), and perceived mother 
trustworthiness, t (306) = 1.93, p = 0.05 (Mlow = 2.49, Mhigh = 2.80).  Participants were 
more likely to follow the mother’s recommendation when they perceived the mother 
source to have higher competence, higher caring, and higher trustworthiness.  Therefore, 
Hypothesis 1 was fully supported for the outcome variable participant’s likelihood to 
follow mother’s recommendation.   
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Source credibility and participant’s likelihood to follow doctor’s 
recommendation. Results showed significant differences for perceived doctor 
competence, t (305) = -3.57, p < 0.001 (Mlow = 2.38, Mhigh = 2.80), perceived doctor 
caring, t (305) = -2.85, p = 0.005 (Mlow = 2.48, Mhigh = 2.78), and perceived doctor 
trustworthiness, t (305) = -2.87, p = 0.004 (Mlow = 2.46, Mhigh = 2.78).  Participants were 
more likely to follow the doctor’s recommendation when they perceived the doctor 
source to have higher competence, higher caring, and higher trustworthiness.  Therefore, 
Hypothesis 1 was fully supported for the outcome variable participant’s likelihood to 
follow doctor’s recommendation.   
Table 5.12 
Hypothesis 1 Results for Source Credibility and Participant’s Likelihood 
 Participant’s Likelihood to Follow Recommendation  
 Very unlikely Somewhat 
unlikely 
Somewhat 
likely 
Very Likely p-value 
Mother      
Competence      
Low 
M = 2.96 (SD = .69) 
54.1% (20) 58.0% (58) 41.3% (45) 29.0% (18) 0.001 
High 
M = 4.95 (SD = .81) 
45.9% (17) 42.0% (42) 58.7% (64) 71.0% (44)  
Caring      
Low 
M = 4.18 (SD = .86) 
54.1% (20) 57.0% (57) 48.6% (53) 35.5% (22) 0.02 
High 
M = 6.25 (SD = .56) 
45.9% (17) 43.0% (43) 51.4% (56) 64.5% (40)  
Trustworthiness      
Low 
M = 4.23 (SD = .71) 
37.8% (14) 41.4% (41) 54.1% (59) 51.6% (32) 0.05 
High 
M = 6.19 (SD = .58) 
62.2% (23) 58.6% (58) 45.9% (50) 48.4% (30)  
      
Doctor      
Competence      
Low 
M = 4.01 (SD = 1.04) 
64.3% (27) 59.1% (52) 41.7% (50) 36.8% (21) 0.001 
High 
M = 6.52 (SD = .50) 
35.7% (15) 40.9% (36) 58.3% (70) 63.2% (36)  
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Table 5.12 (continued) 
Caring      
Low 
M = 3.91 (SD = .71) 
54.8% (23) 59.1% (52) 45.8% (55) 33.3% (19) 0.005 
High 
M = 5.93 (SD = .69) 
45.2% (19) 40.9% (36) 54.2% (65) 66.7% (38)  
Trustworthiness      
Low 
M = 4.18 (SD = .74) 
59.5% (25) 55.7% (49) 42.5% (51) 36.8% (21) 0.004 
High 
M = 6.28 (SD = .59) 
40.5% (17) 44.3% (39) 57.5% (69) 63.2% (36)  
 
Research Question 1 
Research Question 1 asked which type of source credibility (competence, caring, 
trustworthiness) best predicts following the source’s recommendation.  Research 
Question 1 was answered using a multiple regression analysis.  Because there were four 
dependent or criterion variables that need to be tested, four multiple regression analyses 
were run. The four dependent variables are Sarah’s likelihood to follow mother 
recommendation, Participant’s likelihood to follow mother recommendation, Sarah’s 
likelihood to follow doctor recommendation, and Participant’s likelihood to follow doctor 
recommendation.  Due to high correlation between some of the source credibility 
predictor variables, all source credibility variables were mean-centered to reduce the risk 
of multi-collinearity in the regression analyses (Chatterjee & Hadi, 2006). 
First, a multiple regression was performed on the dependent variable Sarah’s 
likelihood to follow mother recommendation using the three mother source credibility 
predictor variables (perceived mother competence, perceived mother caring, and 
perceived mother trustworthiness).  The model was not statistically significant, F (3, 302) 
= 0.23, p = 0.87, R2 = .002.  Therefore, the answer to Research Question 1 is that no type 
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of mother source credibility significantly predicts participant’s perception of Sarah’s 
likelihood to follow mother recommendation. 
 Second, a multiple regression was performed on the dependent variable 
Participant’s likelihood to follow mother recommendation using the three mother source 
credibility predictor variables (perceived mother competence, perceived mother caring, 
and perceived mother trustworthiness).  The model was statistically significant, F (3, 
304) = 6.27, p < .001, R2 = .05.    One of the three predictor variables significantly 
predicted participant’s likelihood to follow mother recommendation: perceived mother 
competence ! = .19, p = .02.  Therefore, the answer to Research Question 1 is that 
perceived mother competence is the only type of source credibility that significantly 
predicts Participant’s likelihood to follow mother recommendation. 
 Third, a multiple regression was performed on the dependent variable Sarah’s 
likelihood to follow doctor recommendation using the three doctor source credibility 
predictor variables (perceived doctor competence, perceived doctor caring, and 
perceived doctor trustworthiness).  The model was not statistically significant, F (3, 301) 
= 0.99, p = 0.40, R2 = .01.  Therefore, the answer to Research Question 1 is that no type 
of doctor source credibility significantly predicts participant’s perception of Sarah’s 
likelihood to follow doctor recommendation. 
Fourth, a multiple regression was performed on the dependent variable 
Participant’s likelihood to follow doctor recommendation using the three doctor source 
credibility predictor variables (perceived doctor competence, perceived doctor caring, 
and perceived doctor trustworthiness). The model was statistically significant, F (3, 303) 
= 7.97, p < .001, R2 = .06.    However, only two of the three predictor variables were 
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significant predictors of Participant’s likelihood to follow doctor recommendation: 
perceived doctor competence ! = .23, p = .04 and perceived doctor caring ! = .22, p = 
.048.  Therefore, the answer to Research Question 1 is that perceived doctor competence 
best predicts Participant’s likelihood to follow doctor recommendation, followed by 
perceived doctor caring. 
Research Question 2 
Research Question 2 asked what effect does past conversation with a source have 
on participant’s perceptions of source credibility. A one-way analysis of variance was 
used to assess mean differences between perceptions of mother and doctor competence, 
caring, and trustworthiness based on the types of past conversations participants had with 
these sources (past conversation recommending no vaccination, no past conversation, 
past conversation recommending vaccination). 
Perceived mother credibility. A one-way ANOVA indicated no significant 
differences in participants’ ratings of perceived mother competence across the three 
different past mother conversation scenarios, F (2, 305) = 2.61, p = .075, "2 = .02.  A 
one-way ANOVA indicated a significant difference in participants’ ratings of perceived 
mother caring across the three different past conversation scenarios, F (2, 305) = 4.95, p 
= .008, "2 = .03.  Specifically, LSD post hoc tests indicated that past mother conversation 
recommending no vaccination (M = 5.63) differed significantly (p = .05) from no past 
mother conversation (M = 5.10) and past mother conversation recommending 
vaccination (M = 5.12).  A one-way ANOVA indicated a significant difference in 
participants’ ratings of perceived mother trustworthiness across the three different past 
conversation scenarios, F (2, 305) = 6.74, p = .001, "2 = .04.  Specifically, LSD post hoc 
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tests indicated that past mother conversation recommending no vaccination (M = 5.61) 
differed significantly (p = .05) from no past mother conversation (M = 5.04) and past 
mother conversation recommending vaccination (M = 5.06).  Therefore, the answer to 
Research Question 2 is that the type or nature of past conversation about HPV 
vaccination with a mother or mother source affects participants’ ratings of perceived 
mother caring and perceived mother trustworthiness. Specifically, participants rated the 
mother source in the message as more caring and more trustworthy if they personally had 
a past conversation with their mother or mother figure in which she recommended against 
vaccination than if they had a past conversation with their mother or mother figure in 
which she recommended to get the vaccine or in situations in which the participants had 
no past conversation with their mother or mother figure. 
Perceived doctor credibility. A one-way ANOVA indicated significant 
differences in participants’ ratings of perceived doctor competence across the three past 
conversation scenarios, F (2, 303) = 3.53, p = .03, "2 = .02.  Specifically, LSD post hoc 
tests indicated that past doctor conversation recommending no vaccination (M = 6.22) 
differed significantly (p = .05) from no past doctor conversation (M = 5.28).  A one-way 
ANOVA indicated a significant difference in participants’ ratings of perceived doctor 
caring across the three different past conversation scenarios, F (2, 303) = 6.32, p = .002, 
"2 = .04.  Specifically, LSD post hoc tests indicated that past doctor conversation 
recommending no vaccination (M = 5.73) differed significantly (p = .05) from no past 
doctor conversation (M = 4.67) and past doctor conversation recommending vaccination 
(M = 4.95).  A one-way ANOVA indicated a significant difference in participants’ ratings 
of perceived doctor trustworthiness across the three different past conversation scenarios, 
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F (2, 303) = 4.97, p = .008, "2 = .03.  Specifically, LSD post hoc tests indicated that past 
doctor conversation recommending no vaccination (M = 6.07) differed significantly (p = 
.05) from no past doctor conversation (M = 5.08) and past doctor conversation 
recommending vaccination (M = 5.28).  Therefore, the answer to Research Question 2 is 
that the type or nature of past conversation with a doctor affects participants’ ratings of 
perceived doctor competence, perceived doctor caring, and perceived doctor 
trustworthiness.  Participants rated the doctor source in the message as more competent if 
they personally had a previous conversation with a doctor who recommended against 
vaccination than if they reported no past conversations with a doctor.  Also, participants 
rated the doctor as more caring and more trustworthy if they personally had a past 
conversation with a doctor who recommended against vaccination than if they had a past 
conversation with their own doctor in which s/he recommended to get the vaccine or in 
situations in which the participants had no past conversation with a doctor. 
Hypothesis 2 
Hypothesis 2 predicted that messages with greater perceived argument strength 
will be positively related to participants’ likelihood to follow the message 
recommendation. Hypothesis 2 was analyzed using zero-order correlation between each 
type of perceived argument strength and the likelihood to follow recommendation 
variables. Results are described in detail below and presented in Table 5.13 at the end of 
this section. 
Participants’ ratings of Sarah’s likelihood to follow mother recommendation was 
positively correlated with perceived mother long-term risk message argument strength, r 
(96) = .28, p < .01.  Sarah’s likelihood to follow mother recommendation was not 
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significantly correlated with perceived mother short-term risk message argument strength 
or perceived mother no risk message argument strength.  Therefore, Hypothesis 2 is 
supported for the perceived mother long-term risk message argument strength: 
Participants who perceived the mother’s long-term risk message as stronger were more 
likely to believe Sarah would follow the mother’s recommendation. 
The participant’s likelihood to follow mother recommendation was positively 
correlated with perceived mother short-term risk message argument strength, r (103) = 
.33, p < .01 and perceived mother long-term risk message argument strength, r (97) = 
.58, p < .01, but was not significantly correlated with perceived mother no risk message 
argument strength.  Therefore, Hypothesis 2 is supported for perceived mother short-
term risk message argument strength and perceived mother long-term risk message 
argument strength: Participants who perceived the mother’s short-term risk message and 
long-term risk messages as stronger were more likely to follow the mother’s 
recommendation. 
  Participants’ ratings of Sarah’s likelihood to follow doctor recommendation was 
positively correlated with perceived doctor long-term risk message argument strength, r 
(99) = .21, p < .05, but were not significantly correlated with perceived doctor short-term 
risk message argument strength or perceived doctor no risk message argument strength.  
Therefore, Hypothesis 2 is supported for perceived doctor long-term risk message 
argument strength: Participants who perceived the doctor’s long-term risk message as 
stronger were more likely to follow the doctor’s recommendation.  
The participant’s likelihood to follow doctor recommendation was positively 
correlated with perceived doctor short-term risk message argument strength, r (97) = .40, 
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p < .01, perceived doctor long-term risk message argument strength, r (99) = .51, p < .01, 
and perceived doctor no risk message argument strength, r (94) = .33, p <  .01.  
Therefore, Hypothesis 2 is supported for perceived doctor short-term risk message 
argument strength, perceived doctor long-term risk message argument strength, and 
perceived doctor no risk message argument strength: Participants who perceived all three 
doctor messages as stronger were more likely to follow the doctor’s recommendation. 
Table 5.13 
Hypothesis 2 Correlations between Likelihood and Argument Strength 
 Mother 
short-
term  
Mother 
long-
term  
Mother 
no risk  
Doctor 
short-
term  
Doctor 
long-
term  
Doctor 
no risk  
Sarah’s likelihood to 
follow mother 
recommendation 
.057 .284** -.061    
Participant’s likelihood 
to follow mother 
recommendation 
.329** .582** .127    
Sarah’s likelihood to 
follow doctor 
recommendation 
   .149 .208* -.105 
Participant’s likelihood 
to follow doctor 
recommendation 
   .398** .506** .332** 
Note. **Correlation is significant at the 0.01 level; *Correlation is significant at the 0.05 
level. 
 
Hypothesis 3 and Research Question 3 
Hypothesis 3 predicted that participants who receive messages from doctors and 
mothers that converge on both recommendation and risk (i.e., Conditions 1, 5, 9) will be 
more likely to follow the recommendation given by the doctor than participants who 
receive messages from both sources with mixed message characteristics (divergence on 
risk and convergence on recommendation; i.e., Conditions 7, 3) or divergent message 
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characteristics (divergence on both recommendation and risk; i.e., Conditions 2, 4, 6, 8).  
In addition, Research Question 3 asked, what is the effect of past conversations with a 
source on likelihood to follow the doctor’s recommendation?  Hypothesis 3 and Research 
Question 3 were tested for the outcome variables Sarah’s likelihood to follow the doctor’s 
recommendation and Participant’s likelihood to follow the doctor’s recommendation. 
The decision was made to focus these final analyses on the participants’ likelihood to 
follow a doctor’s recommendation for two reasons: a) formative work revealed that 
doctors were more likely to voice pro-vaccination messages, and so focusing on 
likelihood to follow a doctor’s recommendation is the most advantageous for promoting 
this behavior and b) the focus of future intervention efforts based on the findings from 
this study might more easily be directed toward doctors rather than mothers.   
First, a 3 X 3 (mother argument type X doctor argument type) between-subjects 
univariate ANOVA tested the effects of the type of convergence on Sarah’s likelihood to 
follow the doctor’s recommendation.  Past conversation with mother and past 
conversation with doctor were entered as covariates.   Put simply, Hypothesis 3 predicted 
that messages that converge from both sources on both recommendation and risk will be 
more effective than mixed convergence messages, and that mixed convergence messages 
will be more effective than messages that diverge.  Support for this hypothesis would be 
indicated by a significant mother argument type by doctor argument type interaction.  
The overall model was significant, F (8, 305) = 10.70, p <.001, "2 = .22.  More 
specifically, the two-way interaction term (mother argument type X doctor argument 
type) was statistically significant for Sarah’s likelihood to follow the doctor’s 
recommendation, F (4, 305) = 15.03, p <.001, "2 = .17.   
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Post-hoc tests on individual mean differences for each message condition were 
not appropriate and would not provide a clear report of the mean differences or 
adequately address Hypothesis 3 because the conditions were grouped together in the 
hypothesis according to type of message convergence.  Therefore, a follow-up one-way 
ANOVA on Sarah’s likelihood to follow the doctor’s recommendation was conducted 
across the three difference types of convergence (convergence on recommendation and 
risk, mixed convergence/divergence on recommendation and risk, divergence on 
recommendation and risk).  This analysis was significant: F (2, 305) = 28.99, p <.001, "2 
= .16.  Participants indicated that they more likely believed Sarah would follow the 
doctor’s recommendation in message conditions where there was convergence on 
recommendation and risk (M = 3.21, SD = 0.79), followed by mixed message conditions 
(M = 3.03, SD = 0.78), and finally divergent message conditions (M = 2.52, SD = 0.64).  
LSD post-hoc tests on this analysis revealed that the message convergence conditions as 
a group were significantly greater (p = .05) than the divergent message conditions, and 
the mixed message conditions as a group were significantly greater (p = .05) than 
divergent message conditions. Therefore, Hypothesis 3 was nearly fully supported, 
except for the lack of a significant difference between convergence conditions and mixed 
conditions.  Results for these analyses are displayed visually in Table 5.14 and Table 
5.15. 
Past conversations with both doctor and mother were entered as covariates in the 
model, and the analysis revealed that participants’ perceptions of Sarah’s likelihood to 
follow the doctor’s recommendation did not vary in relation to past conversation with 
doctor or past conversation with mother or mother figure.  Therefore, the answer to 
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Research Question 3 is no, past conversations with a mother or doctor about HPV 
vaccination do not have an effect on participant’s perceptions of Sarah’s likelihood to 
follow the doctor’s recommendation. 
Table 5.14 
Sarah’s Likelihood to Follow Doctor’s Recommendation by Message Condition a 
  Doctor 
   short term risk 
do not get 
vaccinated 
long term risk 
get vaccinated 
no risk 
do not get 
vaccinated 
Mother short term 
risk 
do not get 
vaccinated 
1 
Convergence on risk 
and 
recommendation 
M = 3.30b 
SD = 0.84 
2 
Divergence on 
risk and 
recommendation 
M = 2.60 
SD = 0.60 
3 
Divergence on risk 
but convergence on 
recommendation 
M = 2.94 
SD = 0.80 
long term 
risk 
get 
vaccinated 
4 
Divergence on risk 
and 
recommendation 
M = 2.36 
SD = 0.60 
5 
Convergence on 
risk and 
recommendation 
M = 3.26 
SD = 0.71 
6 
Divergence on risk 
and 
recommendation 
M = 2.18 
          SD = 0.58 
no risk 
do not get 
vaccinated 
7 
Divergence on risk 
but convergence on 
recommendation 
M = 3.11 
SD = 0.69 
8 
Divergence on 
risk and 
recommendation 
M = 2.91 
SD = 0.57 
9 
Convergence on risk 
and 
recommendation 
M = 3.05 
SD = 0.80 
Note. aThe message conditions are shaded according to type of message convergence: 
convergent message conditions are unshaded, mixed message conditions are shaded light 
gray, and divergent message conditions are shaded dark gray.  bThe likelihood to follow 
recommendation variable was measured on a 4-point scale, with higher scores indicating 
a participant is more likely to follow the doctor recommendation.   
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Table 5.15 
Sarah’s Likelihood to Follow Doctor’s Recommendation by Convergence Type 
Convergence 
Type 
Message 
Conditions N Mean SD 
95% Confidence Interval 
for Mean 
Lower 
Bound 
Upper 
Bound 
Converge on All 1  5  9 102 3.21 .79 3.05 3.36 
Mixed 7  3 69 3.03 .75 2.85 3.21 
Diverge on All 2  4  6  8 135 2.52 .64 2.41 2.63 
Total  306 2.86 .78 2.77 2.95 
 
Second, a 3 X 3 (mother argument type X doctor argument type) between-
subjects univariate ANOVA tested the effects of the type of convergence on Participant’s 
likelihood to follow the doctor’s recommendation.  Past conversation with mother and 
past conversation with doctor were entered as covariates.   The overall model was 
significant, F (8, 307) = 2.07, p < .05, "2 = .05.  However, the two-way interaction term 
(mother argument type X doctor argument type) was not statistically significant.  Similar 
to the process followed for the first outcome variable, a follow-up one-way ANOVA 
indicated significant differences on Participant’s likelihood to follow the doctor’s 
recommendation across the three difference types of convergence (convergence on 
recommendation and risk, mixed convergence/divergence on recommendation and risk, 
divergence on recommendation and risk), F (2, 305) = 3.10, p <.05, "2 = .02.  Participants 
indicated that they would be more likely to follow the doctor’s recommendation in 
message conditions in which there was convergence on recommendation and risk (M = 
2.79, SD = 0.91), followed by mixed message conditions (M = 2.65, SD = 0.90), and 
finally divergent message conditions (M = 2.49, SD = 0.96).  LSD post-hoc tests on this 
analysis revealed that message convergence conditions as a group were significantly 
greater (p = .05) than divergent message conditions. Therefore, Hypothesis 3 was 
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partially supported.  Results for these analyses are displayed visually in Table 5.16 and 
Table 5.17. 
Past conversations with both doctor and mother were entered as covariates in the 
model, and the analysis revealed that participants’ perceptions of Participant’s likelihood 
to follow the doctor’s recommendation did significantly vary in relation to past 
conversation with mother, F (1, 305) = 10.27, p <.01   Therefore, the answer to Research 
Question 3 is past conversations with a mother does have an effect on Participant’s 
likelihood to follow the doctor’s recommendation. 
Figure 5.16 
Participant’s Likelihood to Follow Doctor’s Recommendation by Message Condition a 
  Doctor 
   short term risk 
do not get 
vaccinated 
long term risk 
get vaccinated 
no risk 
do not get 
vaccinated 
Mother short term 
risk 
do not get 
vaccinated 
1 
Convergence on risk 
and 
recommendation 
M = 2.83b 
SD = 0.94 
2 
Divergence on 
risk and 
recommendation 
M = 2.63 
SD = 0.88 
3 
Divergence on risk 
but convergence on 
recommendation 
M = 2.66 
SD = 0.97 
long term 
risk 
get 
vaccinated 
4 
Divergence on risk 
and 
recommendation 
M = 2.35 
SD = 1.01 
5 
Convergence on 
risk and 
recommendation 
M = 2.85 
SD = 0.86 
6 
Divergence on risk 
and 
recommendation 
M = 2.15 
          SD = 0.94 
no risk 
do not get 
vaccinated 
7 
Divergence on risk 
but convergence on 
recommendation 
M = 2.65 
SD = 0.85 
8 
Divergence on 
risk and 
recommendation 
M = 2.79 
SD = 0.91 
9 
Convergence on risk 
and 
recommendation 
M = 2.69 
SD = 0.96 
Note. aThe message conditions are shaded according to type of message convergence: 
convergent message conditions are unshaded, mixed message conditions are shaded light 
gray, and divergent message conditions are shaded dark gray.  bThe likelihood to follow 
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recommendation variable was measured on a 4-point scale, with higher scores indicating 
a participant is more likely to follow the doctor recommendation.   
 
Table 5.17 
Participant’s Likelihood to Follow Doctor’s Recommendation by Convergence Type 
Convergence 
Type 
Message 
Conditions N Mean SD 
95% Confidence 
Interval for Mean 
Lower 
Bound 
Upper 
Bound 
Converge on All 1  5  9 103 2.79 .91 2.61 2.97 
Mixed 7  3 69 2.65 .90 2.43 2.87 
Diverge on All 2  4  6  8 136 2.49 .96 2.32 2.65 
Total  308 2.62 .94 2.52 2.73 
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CHAPTER 6 
Discussion 
! The purpose of Study 2 was to provide an experimental test of the MCF in the 
context of HPV vaccination.  This was the first empirical test of the MCF, and the results 
provide support for the main tenets of the theory.  Specifically, in Study 2, participants 
heard messages from both a mother source and a doctor source; these two messages 
converged on the type of risk message and recommendation provided, diverged on the 
type of risk message and recommendation provided, or were mixed in the type of risk 
message and recommendation provided.  Participants were then asked to indicate their 
perceptions of each source’s credibility, their perceptions of the strengths of each 
argument (i.e., message), and finally, their likelihood and their perceptions of Sarah’s 
likelihood to follow each source’s recommendation.  In this discussion chapter, I first 
discuss some of the major implications of Study 2 findings. Next, I discuss the limitations 
of Study 2 including methodological and external validity considerations.  Finally, I 
conclude the chapter with some ideas for future research and health interventions. 
Implications 
The goal of this study was to answer three hypotheses and three research 
questions that explored the persuasive effects of perceptions of source credibility, 
perceptions of argument strength, and the effect of different types of message 
convergence.  The data presented in Chapter 5 provide some evidentiary support to 
address these hypotheses and research questions.  To address the findings that were 
concordant and discordant with the hypotheses and research questions, the following 
sections examine in detail four main discussion points or implications. 
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First, the main outcomes in this study were participants’ perceptions of Sarah’s 
likelihood to follow recommendations from the doctor and mother source and 
participants personal likelihood to follow recommendations from the doctor and mother 
source.  There were some key differences between participants’ responses to Sarah’s 
likelihood to follow a recommendation and their personal likelihood to follow a 
recommendation.   To address these differences, I first describe the overall findings for 
Sarah’s likelihood to follow a recommendation and reserve the remainder of the 
discussion section to focus on participants’ personal likelihood outcome variables. Table 
6.1 offers detail to the reader of each hypothesis or research question, and the findings for 
each outcome variable (Sarah’s likelihood to follow a recommendation and participant’s 
likelihood to follow a recommendation).  
Recall Hypothesis 1 predicted that participants would more likely follow the 
recommendation given by sources they perceive as higher in 
credibility/caring/trustworthiness than sources they perceive as lower in 
credibility/caring/trustworthiness, Research Question 1 asked which type of source 
credibility (competence, caring, trustworthiness) best predicts following the source’s 
recommendation, and Hypothesis 2 predicted that messages with greater perceived 
argument strength will be positively related to participants’ likelihood to follow the 
message recommendation.   Results show that both source credibility and argument 
strength did not have significant main effects (with some minor exceptions) on 
participants’ ratings of Sarah’s likelihood to follow recommendations.  This may suggest 
that, in evaluations of what an “other” would do, certain cues like source credibility and 
argument strength are not important message processing variables for individuals.  In 
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other words, in terms of the ELM, participants are not relying on perceptions of higher 
source credibility or perceptions of stronger arguments as reasons for another person to 
follow a source’s recommendation.   
Alternatively, these data indicate participants’ ratings of Sarah’s likelihood to 
follow a source’s recommendation were almost fully explained by message convergence.  
There were significant differences between message convergent and divergent conditions 
and between mixed message conditions and divergent message conditions and these 
differences were in the hypothesized direction.  It may be that, in the case of evaluating 
what an “other” would do, the message convergence acted as a processing cue for 
participants, such that when messages converged, participants assumed that Sarah would 
follow the doctor’s recommendation because it agreed with the mother’s risk message 
and recommendation.  Compared to convergent and mixed message conditions in which 
scores were at or above 3.0, in message divergent conditions (see Figure 5.1 in Chapter 
5), participants’ scores on Sarah’s likelihood to follow the doctor recommendation 
generally hovered around the 2.5 mark on the 4-point scale; this suggests “neutral 
territory” in that participants’ average scores were in the mid-point of the scale.  This 
may indicate uncertainty in what Sarah would be likely to do, suggesting that divergent 
conditions do create a level of dissonance for participants.  An alternate explanation is 
that such uncertainty was not due to dissonance, but rather the inability for participants to 
evaluate which message source would be more compelling for Sarah in the context of 
divergent recommendations.  However, this idea needs to be further explored. 
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Table 6.1 
Sarah and Participant Comparison of Findings  
Hypothesis/Research 
Question Test a Sarah b Participant 
H1a: Young women will be 
more likely to follow 
mother recommendation if 
perceived higher 
credibility. 
t-test Partially supported 
Higher 
trustworthiness 
predicts more likely 
to follow. 
Fully supported 
Higher competence, 
caring, and 
trustworthiness 
predict more likely 
to follow. 
H1b: Young women will be 
more likely to follow doctor 
recommendation if 
perceived higher 
credibility. 
t-test Not supported Fully supported 
Higher competence, 
caring, and 
trustworthiness 
predict more likely 
to follow. 
RQ1a: Which type of 
source credibility best 
predicts following mother’s 
recommendation? 
Multiple 
Regression 
Not able to 
answer/Model not 
significant 
Perceived mother 
competence is only 
significant predictor 
RQ1b: Which type of 
source credibility best 
predicts following doctor’s 
recommendation? 
Multiple 
Regression 
Not able to 
answer/Model not 
significant 
Perceived doctor 
competence and 
perceived doctor 
caring significant 
predictors 
RQ2a: What is the effect of 
past conversations with 
mother on perceived 
mother credibility? 
One-way 
ANOVA 
N/A Perceived mother 
caring and perceived 
mother 
trustworthiness 
higher if past 
conversation 
recommended no 
vaccine. 
RQ2b: What is the effect of 
past conversations with 
doctor on perceived doctor 
credibility? 
One-way 
ANOVA 
N/A Perceived doctor 
competence, caring, 
and trustworthiness 
higher if past 
conversation 
recommended no 
vaccine 
!
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Table 6.1 (continued)!
H2a:  Young women will 
be more likely to follow 
mother’s recommendations 
in messages perceived as 
strong. 
Bivariate 
correlation 
Partially supported 
Participants more 
likely to follow 
recommendation in 
stronger long-term 
risk message, but 
not in other 
message conditions 
Partially supported 
Participants more 
likely to follow 
recommendations in 
stronger short-term 
and stronger long-
term risk message, 
but not in no risk 
message condition 
 
H2a:  Young women will 
be more likely to follow 
doctor’s recommendations 
in messages perceived as 
strong. 
Bivariate 
correlation 
Partially supported 
Participants more 
likely to follow 
recommendation in 
stronger long-term 
risk message 
Fully supported 
Participants more 
likely to follow 
recommendations in 
(all) arguments they 
perceive as stronger 
H3: Young women will 
follow doctor’s 
recommendation more in 
convergent message 
conditions than in mixed 
and more in mixed 
conditions than in divergent 
conditions. 
Univariate 
ANOVA 
cNearly Fully 
Supported 
Participants 
followed 
recommendations 
more in convergent 
conditions than in 
mixed conditions 
and divergent 
conditions 
Partially Supported 
Participants followed 
recommendations 
more in convergent 
conditions than in 
divergent conditions 
RQ3: What is the effect of 
past conversations with a 
source on likelihood to 
follow doctor’s 
recommendation? 
Entered as 
Covariates in 
ANOVA  
Not able to 
answer/Not 
significant 
covariates 
Past conversations 
with mother has an 
effect on 
participant’s 
likelihood to follow 
doctor’s 
recommendation 
Note a The Sarah column represents the outcome Sarah’s likelihood to follow a 
recommendation. b The Participant column represents the outcome Participant’s 
likelihood to follow a recommendation. c Please see Chapter 5 Results section for a 
detailed description of why these hypotheses are labeled “nearly fully supported;” space 
limitations in the table prevent a thorough description. 
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Second, source credibility and argument strength proved important predictors of 
participants’ personal likelihood to follow a source’s recommendation.  Participants were 
more likely to follow a source’s recommendation (both mother and doctor) when they 
perceived the source to be more competent, caring, and trustworthy, and when they 
perceived the argument the source was making to be strong. However, recall that 
individuals read messages from both sources at the same time and therefore it may be 
unclear what role source credibility and argument strength played in how individuals 
processed these messages.  In past message testing studies, it has been typical for 
participants to read a message from one source and then evaluate that individual source’s 
credibility (Stiff & Mongeau, 2003).  By asking participants to read messages from two 
sources at the same time and then evaluate each source’s credibility, it may be that 
participants made comparisons in their mind that also reflected upon their credibility 
assessments.  Did these source variables act as peripheral cues, such that a more credible 
source acted as a cue for a participant to follow that recommendation rather than a less 
credible source?   
Alternatively, given that individuals read messages from both sources at the same 
time, did source credibility prompt individuals to centrally process the source attributes?  
Past research says that while source credibility typically serves as a peripheral cue, it can 
act as a central cue in some instances in which source credibility is important in the 
decision (O’Keefe, 2002).  I would posit that in cases in which two sources are “pitted” 
against each other, like what was done in Study 2, source credibility serves more as a 
central processing cue.  However, future research needs to examine this idea using 
measures such as thought listing tasks that assess central processing.  Additionally, the 
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role of argument strength, often relied on as an indicator of central processing, needs 
further examining in the context of multiple messages.  Even if it is true that an 
individual believes a message is strong (and the source is credible), she may still choose 
not to follow the recommendation given by that particular source if she is confronted with 
a message and recommendation from another source that is also argumentatively strong 
and credible.   
Third, recall that Research Question 2 asked what effect does past conversation 
with a source have on participant’s perceptions of source credibility.  Results revealed 
that past conversations with a source had an effect on a participant’s perceptions of 
source credibility and likelihood to follow a recommendation from that “same” source.  
In other words, past conversations about HPV vaccination matter, lending support to the 
notion that the communication environment around an issue (e.g., HPV vaccination) 
should be seen more as a movie reel and not a snapshot of one point in time.  
Specifically, the type of past conversation revealed that participants reacted to messages 
from a similar source (in this case, Sarah’s mother and doctor) in different ways.  By 
that, I mean that participants perceived a source’s credibility in different ways depending 
on their past communication with a source.  For example, the mother source (regardless 
of message condition) was perceived as more caring and more trustworthy if the 
participant had personally discussed HPV vaccination with her mother in the past and the 
mother had recommended against vaccination, than if participants had past conversations 
in which the participant’s mother had recommended for vaccination or if no past 
conversations had occurred.  It is unclear why this is the case.  However, one possible 
explanation can be drawn from the study sample itself.  Because the women in the study 
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were unvaccinated, if the participants had personally discussed HPV vaccination in the 
past, she clearly had considered vaccination and chosen not to vaccinate.  In asking 
participants to consider the credibility of the mother source in the scenario, it may be that 
participants considered mothers who chose to discuss vaccination with their daughters, 
even though this was a hypothetical scenario with “Sarah’s” mother, as more caring and 
trustworthy because they cared enough to talk about it.  After all, this finding was 
significant regardless of the recommendation in the message scenarios (i.e., the mother 
recommending to get the vaccine or recommending not to get the vaccine).  
The same pattern was seen for past conversations with a doctor; the doctor source 
in this experiment was perceived as more competent, more caring, and more trustworthy 
if a participant had personally discussed HPV vaccination with her own doctor in the past 
and that doctor had recommended against vaccination.  In the case of doctors, the same 
possible explanation for mothers may be at play.  In sum, this study revealed that past 
conversations with a source do have an impact on a person’s processing of current 
messages, lending support to the idea that individuals process current risk messages 
through a personal frame of reference (Sellnow, Ulmer, Seeger, & Littlefield, 2009). This 
frame of reference includes an individual’s past exposure to messages about the topic 
whether from the same or a similar source. However, future research is needed to further 
examine the effect of past communication about a health topic on an individuals’ 
processing of current communication about the same topic. 
 Fourth, this first test of the message convergence framework revealed support for 
the model.  The model’s main proposition, that message convergence by multiple sources 
will lead participants to be more persuaded to follow the recommendation, now has 
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empirical support.  There are a variety of cognitive functions that may be at work to 
explain why convergence provides the strongest behavioral intention effect.  For 
example, in the case of likelihood to follow a doctor’s recommendation in Study 2, 
participants may have seen the mother’s message as reinforcing what the doctor was 
saying and therefore felt more assured that the behavior the doctor was advocating was 
indeed possible.  Alternatively, much like participants’ ratings of Sarah’s likelihood to 
follow the doctor’s recommendation in divergent message conditions, participants’ 
average scores on their likelihood to follow the doctor’s recommendation in divergent 
conditions were in the 2.15-2.79 range, suggesting a potential level of uncertainty in 
whether they should follow the recommendation.  This was also the case in mixed 
message conditions; participants’ scores ranged from 2.65-2.66.  Recall that in these 
“mixed” conditions, participants read messages that diverged on the type of risk (i.e., the 
short term risk of getting the vaccine or the lack of risk of becoming infected with HPV) 
but converged on recommendation (i.e., do not get vaccinated).  Despite the fact that 
there wasn’t a significant difference between convergent and mixed conditions or 
divergent and mixed conditions on this outcome variable, mean directions suggest that 
the mixed message conditions do fall between convergent and divergent conditions.  This 
may be the most interesting finding and one that needs further exploration – a convergent 
recommendation is not the only part of the message that’s important – participants may 
also need a convergent message (or argument) for why they should follow this 
convergent recommendation. 
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Limitations 
 There were many limitations to Study 2 that deserve attention and that readers 
should be aware of as they consider the results of this project.  I will organize the 
limitations around experimental design, measurement and related data analysis issues, 
and finally, external validity threats. 
First, perhaps the most difficult part of designing Study 2 was identifying how to 
test the MCF.   This was the first test of MCF and there was little guidance in the research 
literature for designing an experiment like this one.  The experimental design used in this 
message testing study was somewhat unusual compared to other persuasive health 
message testing studies in three ways. First, even though several of the hypotheses and 
research questions concerned the effect of each source (i.e., mother and healthcare 
provider), in every message condition, the participants read messages from both sources. 
In other words, source was not a manipulated variable in the factorial design but it was an 
IV of interest.  Second, and related, the message manipulation came in the form of type 
of argument (3 levels; short term risk of vaccine, long term risk of cervical cancer, and 
lack of risk) and the type of recommendation (2 levels; recommends get the vaccine, 
recommends against vaccination) from each source.  However, in the manipulation of the 
second independent variable (type of recommendation), it was necessary to expose 
participants to the negative recommendation in more than one experimental condition 
(i.e., participants read a negative recommendation in both short term risk argument and 
lack of risk argument).  Because of this, a true factorial design was not possible because 
one of the IVs (recommendation type) was represented in more than one “column” of the 
message matrix usually associated with a factorial design.  See Table 5.4 for a visual 
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depiction of these message conditions.  Related, the type of risk messages tested in this 
study differed in terms of the locus of risk (i.e., risk of the vaccine, risk of cervical 
cancer, and lack of risk for contracting HPV); this is something that could have been 
addressed in a more sensitive manner in the data analysis in order to control for these 
differences.  Third, the main hypothesis concerning the experimental message testing 
concerned the convergence/divergence of messages in each experimental condition and 
not the usual main or interaction effects of individual or combined IVs, thus further 
making a test of this true factorial design not necessary.   Despite these unusual 
conditions, I believe that this experimental design did allow for an adequate first test of 
the message convergence framework.  Future research should attempt to conduct more 
sophisticated tests of the model.   
Second, because of little guidance in the published literature on research design, 
the data analysis required some extra work, such as recoding a number of variables and 
creating a number of variables after data collection occurred in order to fully address the 
research questions and hypotheses.  For example, in most if not all persuasion and health 
behavior change research, the outcome variable is behavioral intention to adopt the 
behavior.  Here, this study design initially used a behavioral intention outcome measure 
(i.e., intention to vaccinate), which is common in vaccination studies.  However, the true 
outcome in message convergence research should be likelihood or intention to follow a 
message recommendation, whatever that may be.  Therefore, the vaccination intention 
measure that participants answered had to be recoded into a likelihood to follow the 
recommendation measure.   
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Related, I could have conducted more sophisticated analyses on source credibility, 
argument strength, and the role of past communication about HPV vaccination.  For 
example, participants’ past conversations about HPV vaccination with both their own 
mothers and their own healthcare providers was measured and each individual’s past 
conversation types (i.e., type of past conversation with a mother, type of past 
conversation with a doctor) were entered as covariates in the ANOVA testing the 
different message conditions on likelihood to follow the doctor’s recommendation 
outcome.  However, a combined variable reflecting whether the type of past conversation 
with a mother converged or diverged with the type of past conversation with a doctor 
may have been a more interesting covariate to test in the model.   Additionally, 
measuring more than just past communication with these two sources and their effect on 
participants’ message processing may have provided a more fitting test of the MCF, 
which seeks to consider all possible communication about a topic.  Despite this, the 
number of participants in this study limited the feasibility of testing interactions among 
many covariates and I made the decision instead to test the main propositions in the 
model (i.e., convergence or divergence among two sources) at the expense of these more 
detailed nuances (i.e., the effect of a more thorough examination of past communication 
on message processing).   Future work should strive to investigate important covariates, 
as informed by formative work around the behavior of interest. 
 Related, there were also a number of measurement limitations.  First, two of the 
variables measured in this study may have lacked a strong conceptual fit.  As previously 
mentioned, the main outcome variable (likelihood to follow a recommendation) was 
recoded from a vaccine behavioral intention measure.  In addition, the past conversation 
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measure only measured the type of past conversation (no past conversation, past 
conversation recommending no vaccination, and past conversation recommending 
vaccination).  This suggests that participants only had one past conversation with each of 
these sources and therefore this measure did not capture the extent of past conversation 
(e.g., one conversation, multiple conversations), nor did it measure the quality of the 
conversation (e.g., whether the source was deemed credible, whether participants 
believed the argument was strong).  The measure also failed to include other sources of 
past conversations or communication about HPV vaccination (which were identified in 
Study 1).  Additionally, to simplify the study design, only the two most important sources 
identified in Study 1 for HPV vaccination information (i.e., mother and doctor) were 
tested in Study 2.  
There also may have been a number of potentially important variables that were 
not measured, and therefore I was unable to see if they made a significant difference in an 
individual’s processing of HPV vaccination messages.  For example, a participant’s 
personal sexual history could have had an impact on her processing of the messages she 
received in the experimental scenario, which identified that Sarah was not a virgin but 
that her mother and doctor (the sources of the messages for the experiment) did not know 
this.  In fact, one of the messages that participants received from the doctor and/or mother 
concerned the lack of risk of contracting HPV because the source believed that Sarah was 
a virgin.  Other important variables of interest to this study that were not measured and/or 
not included in analyses include attitudes and beliefs about vaccinations in general, other 
cervical cancer-related behaviors like Pap testing and HPV testing history, geographic 
location of participants (as well as where they grew up, if it is different from their current 
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location), religious and political beliefs, and family communication norms (which may 
reveal why a participant would follow a family member’s recommendation more than a 
non-family member like a doctor).  In addition, there may have been other important 
covariates that may have proven important if they had been included in the study and 
future research, including more formative work on what variables may be important to 
include, is needed.  
 Finally, given the applied nature of this research project, I would be remiss to not 
discuss external validity considerations.  The sample for Study 2 was young adult 
unvaccinated women from Kentucky, which limits the generalizability of the findings 
beyond this population.  However, there are also several strengths to this sample.  First, 
the formative work completed in Study 1, which informed the experimental messages in 
Study 2, was conducted with a similar sample (young adult unvaccinated women from 
Kentucky); therefore the findings are highly generalizable to this particular population.  
Second, and related, both studies used unvaccinated women, which would be a relevant 
target population for any HPV vaccination uptake intervention.  Third, the geographic 
focus in Kentucky is important given the previously discussed high cervical cancer rates 
and relatively low HPV vaccination rates.  Another external validity consideration is the 
medium used in this message testing study.  The stimulus was text-based.  A more 
realistic test may have been to use video messages of each source delivering a message.  
However, the text-based messages allowed for the study to be easily completed on the 
Internet and it also allowed for participants to be reminded of the source and message 
when answering each question (i.e., as a reminder, participants saw the “mother” message 
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at the top of the screen while they filled out the mother source credibility and mother 
argument strength measures; the same held true for the “doctor” message). 
Future Directions 
There are two areas for future research with regard to this study.  The first is in 
regard to research and intervention design for increasing HPV vaccination among young 
adult women.  The findings from Study 2 reveal important information about how 
messages from different sources have an effect on likelihood to receive the HPV vaccine.  
While single-source and single-message research is valuable in helping us understand 
communication influences, this study reveals that researchers need to move beyond single 
message research designs to consider multiple communication influences.  Perhaps the 
most important piece of information that was learned (or, confirmed) in this study is that 
recommendations for health behaviors do not happen in a vacuum.  Moving forward, 
developing more sensitive understandings of these multiple recommendations and 
teaching healthcare providers how to talk to patients will help us to better increase HPV 
vaccine uptake. Elder, Ayala, and Harris (1999) suggest a number of provider counseling 
actions informed by health behavior change theories, including having the provider “elicit 
from the patient potential cues he/she is exposed to on a daily basis” such as media 
messages as well as “determine whether family members and friends endorse the 
behavior [and]… highlight these endorsements if they exist” (p. 278).  In this way, 
healthcare providers can capitalize on message convergence being an effective method of 
behavior change and work to help the patient “see” the message convergence in their 
communication environment.   
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However, in cases in which patients may be receiving conflicting or divergent 
messages and recommendations (or, alternatively, no messages) from others in their 
communication environment, the provider’s actions for encouraging vaccination are less 
clear.  Despite this, healthcare providers cannot know a patient’s history with regard to 
HPV vaccination communication unless they elicit that information from the patient.  
Perhaps starting the HPV vaccination conversation by simply asking “what have you 
heard about this vaccine?” is a good first step in opening up the dialogue and learning 
what patients have heard.  Such a conversation will help healthcare providers better 
assess what past messages a patient has received. This is especially relevant to the 
population of young adult women, who may still be influenced by their mother and other 
family members when it comes to health, even though they are over 18 and are most 
likely making independent health decisions.  For example, healthcare providers can enlist 
the use of others in the patient’s life to encourage behavior change.  Elder, Ayala, and 
Harris (1999) note that “support for change can be elicited from family members or close 
friends” and doctors can “invite key family members into a discussion with the patient” 
to help reinforce the benefits of behavior change (p. 280). 
The second major implication for future research is that this framework (MCF) 
and this research design (examining the effect of more than one persuasive message) 
should be tested in other health communication contexts.  Given the significant findings 
shown here, it is reasonable to assume that other “controversial” health behaviors may 
benefit from a message convergence framework analysis.  For example, consider the 
topic of voluntary mastectomies due to testing positive for the BRCA gene.  Angelina 
Jolie made national headlines when she shared her personal story around this decision 
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(Jolie, 2013), but it’s something that thousands of women may deal with at some point in 
their lives.  This is a behavior for which there may be multiple messages about the topic – 
some encouraging, some discouraging – and better understanding how a woman sorts 
through these messages can allow health communication scholars to better design 
messages and social support programs for women who find themselves in a similar 
situation.  Another health topic that may benefit from this analysis is breast feeding.  
While this is a decision that is easy for some women, others may find it difficult to decide 
to breast feed (or decide to continue to breast feed) due to the messages they receive 
about this behavior from spouses, parents, in-laws, peers, rude people in public, etc.  
Surprisingly, there is little published communication research on the discourse around 
breastfeeding (Foss, 2013; Gray, 2013).  In sum, while it is clear that these two research 
ideas center specifically on women’s health (a personal research bias, I admit!), any 
health behavior in which an individual may receive conflicting messages from different 
sources over time about what to do regarding a health issue is a ripe area for study from 
this framework. 
Conclusion 
The purpose of this research project was to better understand the communication 
environment about HPV vaccination and how multiple messages from different sources 
interact to influence HPV vaccination decisions.  The project contained two studies.  In 
Study 1, the message convergence framework was used to analyze interviews with 
unvaccinated young adult women who discussed past messages they received about HPV 
vaccination and the effect those messages had on their HPV vaccine decision.  In Study 
2, the findings from Study 1 were used to design an experiment to test these typical 
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messages and message sources and determine in which conditions (convergence, 
divergence, or mixed) a participant was more likely to follow a recommendation.  In sum, 
this research project succeeded in achieving its objectives.  We now have a clearer idea of 
what the HPV vaccination communication environment “looks” like for young adult 
women, and we have a better understanding of how multiple HPV vaccination messages 
influence decision-making. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Katharine J. Head 2013  
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Appendix A 
Consent Form 
Consent to Participate in a Research Study 
Understanding Patient Perspectives on Cervical Cancer Prevention 
 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH?  
You are being invited to take part in a research study about your perspectives on cervical 
cancer prevention. You are being invited to take part in this research study because you 
are a female between the ages of 18 and 30 years old.  If you choose to take part in this 
study, you will be one of about 300 women to do so in the Lexington area. 
 
 WHO IS DOING THE STUDY?  
The person in charge of this study is Katharine Head (Principal Investigator, PI) of the 
University of Kentucky’s Department of Communication.  She is a doctoral student and 
is being guided in this research by Dr. Elisia Cohen. 
 
WHAT IS THE PURPOSE OF THIS STUDY? 
This research study will help Katharine better understand young adult women’s 
perspectives on cervical cancer prevention.  All answers to your questions will be kept 
confidential.  In addition, you understand that all information from the study will be used 
only for research purposes.  Although you may not get personal benefit from taking part 
in this research study, your responses may help us understand more about how young 
women like you communicate about cervical cancer prevention. 
ARE THERE REASONS YOU SHOULD NOT TAKE PART IN THIS STUDY? 
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If you are under 18 years of age or over 30 years of age you will not be able to participate 
in this study.  There are questions of a sensitive nature included in the study, mostly 
about issues related to women’s health and wellbeing.  Your responses will be kept 
confidential.  Although we have tried to minimize the number of sensitive questions that 
we ask, some questions may make you upset or feel uncomfortable or embarrassed, and 
you may choose not to answer them.  If some questions do upset you, we can tell you 
about some people who may be able to help you with these feelings. 
 
 WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT 
LAST?   
You will need to complete one web-based survey for the study which will take 
approximately 15-20 minutes to complete.  This survey will be completed at your 
convenience on a computer.   
 
WHAT WILL YOU BE ASKED TO DO? 
You will be asked to answer questions on a web-based survey (on the computer).  These 
questions will ask about your knowledge, thoughts, and feelings about cervical cancer 
prevention and women’s health.  As part of the survey, you will also be asked to respond 
to a scenario about cervical cancer prevention.  You will complete this survey at your 
own convenience (for example, on your home computer). After reading this informed 
consent statement and agreeing to participate in the study, you can proceed to completing 
this web-based survey.  
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WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
To the best of our knowledge, the things you will be doing have no more risk of harm 
than you would experience in everyday life.  The only possible risks to you are any 
discomfort or embarrassment you might feel answering some of the survey questions. If 
so, we can tell you about some people who may be able to help you with these 
feelings.  However, this risk should be no greater than what you would experience in 
everyday conversations with other people such as yourself about these issues.  In addition 
to the risks listed above, you may experience a previously unknown risk or side effect. 
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
There is no guarantee that you will get any benefit from taking part in this 
study.  However, some people have experienced increased knowledge and understanding 
about cervical cancer prevention and women’s health after participating in similar 
studies.  Your willingness to take part, however, may in the future help society as a whole 
better understand this research topic. 
  
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be because you really want to 
volunteer.  You have a choice about whether or not to complete the survey, and if you do 
participate, you are free to skip any questions or discontinue at any time.  As a student, if 
you decide not to take part in this study, you may want to choose to participate in other 
research projects to fulfill course requirements. 
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IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER 
CHOICES? 
If you do not want to take part in this research study, you can withdraw from the 
study.  Participants who signed up for this study to earn Communication research credit 
for their Communication course(s) can choose to earn their required research credit by 
signing up for other research projects offered by the Department of Communication. 
 
WHAT WILL IT COST YOU TO PARTICIPATE? 
There are no direct costs associated with taking part in the study.  
  
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
For students enrolled in lower level Communication courses and who signed up as part of 
the SONA Research Recruitment System, you will receive course credit for 
participating.  Specifically, you will receive one (1) research credit.  This credit will be 
granted to you at the conclusion of your participation.  For participants who signed up as 
a volunteer to participate in this study, you will receive a $10 gift card to the business of 
your choice (Target or Starbucks) for participation in this study. 
 
WHO WILL SEE THE INFORMATION THAT YOU GIVE?  
We will make every effort to keep private all research records that identify you to the 
extent allowed by law.  We may be required to show some study information, such as 
information that identifies you, to people who need to be sure we have done the research 
correctly.  These would be people from such organizations as the University of Kentucky. 
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Your name will not be attached to any of the materials that you complete during the 
study.  Please be aware, while we make every effort to safeguard your data once received 
from the online survey/data gathering company, given the nature of online surveys, as 
with anything involving the Internet, we can  never guarantee the confidentiality of the 
data while still on the survey/data gathering company’s servers, or while en route to 
either them or us.  It is also possible the raw data collected for research purposes may be 
used for marketing or reporting purposes by the survey/data gathering company after the 
research is concluded, depending on the company’s Terms of Service and Privacy 
policies. 
Your information will be combined with information from other people taking part in the 
study. When we write about the study to share it with other researchers, we will write 
about the combined information we have gathered. You will not be personally identified 
in these written materials. We may publish the results of this study; however, we will 
keep your name and other identifying information private as it will not be linked to your 
responses.  This study is confidential.   However, it should be noted that researchers can 
be forced by law to tell people who are not connected with the study, including the 
courts, about your participation. 
 
CAN YOUR PARTICIPATION IN THE STUDY END EARLY? 
If you decide to take part in the study, you still have the right to decide at any time that 
you no longer want to continue. You also may skip any question that you do not wish to 
answer. You will not be treated differently if you decide to skip questions or stop taking 
part in the study.  
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WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR 
COMPLAINTS? 
Before you decide whether to accept this invitation to take part in the study, please ask 
any questions (by contacting Katharine Head through email at katharine.head@uky.edu) 
that might come to mind now.  Later, if you have questions, suggestions, concerns, or 
complaints about the study, you can contact the investigator, Katharine Head, at 
katharine.head@uky.edu.  If you have any questions about your rights as a volunteer in 
this research, contact the staff in the Office of Research Integrity at the University of 
Kentucky at 859-257-9428 or toll free at 1-866-400-9428.  Thank you in advance for 
your assistance with this important project. 
IMPLIED CONSENT 
Below, please select "Continue" if you would like to complete the survey. By choosing to 
complete the web-based survey, you are providing implied consent to participate in the 
research project.  You may print this consent form for your records or the researcher will 
provide a paper copy for you at your request. 
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Appendix B 
!
Experimental Survey 
 
Internet Survey Questions 
Note: Questions include the variable label (Gender), followed by the question/directions 
that were given to the participant for that question (What is your gender?), followed by 
the answer choices as well as what value each variable level was given (1 = Male, 2 = 
Female).  A link to login to the actual online survey, which may provide a better 
understanding of the flow of the survey, can be provided upon request. 
 
Gender What is your gender? 
! Male (1) 
! Female (2) 
 
ClgClass What is your college classification? 
! Freshman (1) 
! Sophomore (2) 
! Junior (3) 
! Senior (4) 
! Graduate Student (5) 
! Does not apply (6) 
 
Race What is your race? 
! White/Caucasian (1) 
! African American (2) 
! Hispanic (3) 
! Asian (4) 
! Native American (5) 
! Pacific Islander (6) 
! Other (7) 
 
Age How old are you? 
! 17 or younger (17) 
! 18 (18) 
! 19 (19) 
! 20 (20) 
! 21 (21) 
! 22 (22) 
! 23 (23) 
! 24 (24) 
! 25 (25) 
!
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! 26 (26) 
! 27 (27) 
! 28 (28) 
! 29 (29) 
! 30 (30) 
! 31 or older (31) 
 
RcvdHPVvac Have you received the HPV vaccine? 
! Yes (1) 
! No (2) 
(If yes, participant proceeds to page 3; if no, participant proceeds to page 5.) 
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[If yes, received HPV vaccine…] 
 
Howmany How many doses (shots) of the HPV vaccine have you received? 
! One dose (1) 
! Two doses (2) 
! Three doses (3) 
 
Age1stdose At what age did you receive the first dose (shot) of the HPV vaccine? 
! Under 10 (10) 
! 11 (11) 
! 12 (12) 
! 13 (13) 
! 14 (14) 
! 15 (15) 
! 16 (16) 
! 17 (17) 
! 18 (18) 
! 19 (19) 
! 20 (20) 
! 21 (21) 
! 22 (22) 
! 23 (23) 
! 24 (24) 
! 25 (25) 
! 26 (26) 
 
HS1stdose Were you in high school when you received the first dose (shot) of the HPV 
vaccine? 
! Yes (1) 
! No (2) 
 
LivSit What was your living situation when you received the first dose (shot) of the HPV 
vaccine? 
! Living at home with parents (1) 
! Living away from home (2) 
! Other (please explain): (3) ____________________ 
 
Hlthcre1st At the time you received the first dose (shot) of the HPV vaccine, what type of 
healthcare program or payment type did you use? 
! Private insurance (for example, your parent’s insurance) (1) 
! Private pay (for example, paying for health services like the vaccine on your own) (2) 
! Public assistance (for example, Medicaid or the Vaccines For Children [VFC] 
program) (3) 
! Other (please explain): (4) ____________________ 
!
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! Don't know (5) 
 
HlthcreNOW What type of healthcare program or payment type do you use now? 
! Private insurance (for example, your parent’s insurance) (1) 
! Private pay (for example, paying for health services like the vaccine on your own) (2) 
! Public assistance (for example, Medicaid or the Vaccines For Children [VFC] 
program) (3) 
! Other (please explain): (4) ____________________ 
! Don't know (5) 
  
!
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HPVBelfs What are your general thoughts on the HPV vaccine? 
 Strongly 
Disagree (1) 
Somewhat 
Disagree (2) 
Somewhat 
Agree (3) 
Strongly Agree 
(4) 
The HPV 
vaccine might 
cause short term 
problems, like 
fever. (1) 
!  !  !  !  
The HPV 
vaccine might 
cause short term 
problems, like 
pain at the 
injection site. 
(2) 
!  !  !  !  
The HPV 
vaccine might 
cause short term 
problems, like a 
rash. (3) 
!  !  !  !  
The HPV 
vaccine is being 
pushed to make 
money for drug 
companies. (4) 
!  !  !  !  
The HPV 
vaccine might 
cause long-
lasting health 
problems that 
we don’t yet 
know about. (5) 
!  !  !  !  
If a teenage girl 
gets the HPV 
vaccine, she 
may be more 
likely to have 
sex. (6) 
!  !  !  !  
I think the HPV 
vaccine is 
unsafe. (7) 
!  !  !  !  
Teenage girls 
are too young to 
get a vaccine 
for a sexually 
transmitted 
!  !  !  !  
!
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disease like 
HPV. (8) 
HPVEffect   
 Slightly 
Effective (1) 
Moderately 
Effective (2) 
Very Effective 
(3) 
Extremely 
Effective (4) 
How effective 
do you think 
the HPV 
vaccine is in 
preventing an 
HPV infection? 
(1) 
!  !  !  !  
How effective 
do you think 
the HPV 
vaccine is in 
preventing 
cervical cancer? 
(2) 
!  !  !  !  
 
[Participants who answered yes to receiving HPV vaccine finish the survey at this point.] 
 
CnvDoc Have you ever discussed HPV vaccination with a healthcare provider? 
! Yes (1) 
! No (2) 
[If yes, participant proceeds to next two questions; if no, participant skips next two 
questions.] 
 
 RecDoc Did the provider... 
! Recommend that you receive the HPV vaccine. (1) 
! Recommend that you not receive the HPV vaccine. (2) 
 
InfoDoc What types of information did the healthcare provider tell you about the 
vaccine?  Please describe. 
 
CnvMom Have you ever discussed HPV vaccination with your mom or a mother figure in 
your life? 
! Yes (1) 
! No (2) 
[If yes, participant proceeds to next two questions; if no, participant skips next two 
questions.] 
 
RecMom Did your mom (or mother figure)... 
!
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! Recommend that you receive the HPV vaccine. (1) 
! Recommend that you not receive the HPV vaccine. (2) 
 
InfoMom What types of information did your mom (or mother figure) tell you about the 
vaccine?  Please describe. 
 
BlfsGetVc1 Please indicate how much you agree or disagree with the following 
statements about getting the HPV vaccine 
 Strongly 
Disagree (1) 
Somewhat 
Disagree (2) 
Somewhat 
Agree (3) 
Strongly Agree 
(4) 
I absolutely will 
not get the HPV 
vaccine. (1) 
!  !  !  !  
I would 
consider getting 
the HPV 
vaccine if I had 
more 
information 
about it. (2) 
!  !  !  !  
I would get the 
HPV vaccine if 
it wasn’t so 
expensive. (3) 
!  !  !  !  
I would get the 
HPV vaccine if 
I had time in my 
busy schedule. 
(4) 
!  !  !  !  
I don’t have 
enough 
information 
about the HPV 
vaccine to 
decide whether 
to get it. (5) 
!  !  !  !  
The HPV 
vaccine is so 
new that I want 
to wait a while 
before deciding 
if I should get 
it. (6) 
!  !  !  !  
Because I’m not 
sexually active 
!  !  !  !  
!
131 
right now, I 
don’t need the 
HPV vaccine. 
(7) 
 
GetVacTim1 Are you seriously thinking of getting the HPV vaccine? 
! Yes, I would probably get the HPV vaccine today. (4) 
! Yes, I would probably get the HPV vaccine within the next 30 days. (1) 
! Yes, I would probably get the HPV vaccine within the next 6 months. (2) 
! No, I am not thinking of getting the HPV vaccine in the future. (3) 
STIMULUS 
Now, we want you to read a story about a young women who is deciding whether to get 
the HPV vaccine.  She hears information about the vaccine from a couple of different 
sources, which may influence her decision.  Please read Sarah's story and respond to the 
questions.      
 
Sarah is a 20 year old sophomore at the University of Kentucky.  She has had sex a 
couple of times while in college, although she has not told her mother or doctor that she 
is sexually active.   
 
She is trying to decide whether she should get the HPV vaccine.  She knows that HPV is 
a common sexually transmitted disease among college-aged women.  She also knows that 
a vaccine is available to protect against the types of HPV known to cause cervical cancer.   
 
Sarah hears messages about the HPV vaccine from both her doctor and her mother.       
 
At this point, participants are randomly assigned to message condition.  Within each 
message condition, participants are randomly assigned to read the mother or doctor 
message first. 
 
Argument Strength Indicate how much you agree or disagree with the following 
statements. 
 Strongly 
Disagree (1) 
Somewhat 
Disagree (2) 
Somewhat 
Agree (3) 
Strongly Agree 
(4) 
The 
mother’s/doctor’s 
statement is a 
reason for not 
getting the HPV 
vaccine/for 
getting the HPV 
vaccine that is 
believable. (1) 
!  !  !  !  
!
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The 
mother’s/doctor’s 
statement is a 
reason for not 
getting the HPV 
vaccine/for 
getting the HPV 
vaccine that is 
convincing. (2) 
!  !  !  !  
The 
mother’s/doctor’s 
statement gives a 
reason for not 
getting the HPV 
vaccine/for 
getting the HPV 
vaccine that is 
important to me. 
(3) 
!  !  !  !  
The 
mother’s/doctor’s 
statement put 
thoughts in my 
mind for not 
wanting to get 
the HPV 
vaccine/for 
wanting to get 
the HPV vaccine. 
(4) 
!  !  !  !  
Overall, how 
much do you 
agree or disagree 
with what Sarah's 
mother/Sarah’s 
doctor had to say 
about the HPV 
vaccine? (5) 
!  !  !  !  
 
Argument Strength_Reason   
 Very Weak (1) Somewhat 
Weak (2) 
Somewhat 
Strong (3) 
Very Strong 
(4) 
Is the reason 
Sarah's 
mother/Sarah’s 
doctor gave for 
!  !  !  !  
!
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not getting the 
HPV vaccine/for 
getting the HPV 
vaccine a strong 
or weak reason? 
(1) 
 
Credibility On the scales below, indicate your feelings about Sarah's mother/Sarah’s 
doctor in this story.   
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5) 6 (6) 7 (7) 
Intelligent: 
Unintelligent 
(1) 
!  !  !  !  !  !  !  
Untrained: 
Trained (2) 
!  !  !  !  !  !  !  
Cares about 
Sarah: Doesn't 
care about 
Sarah (3) 
!  !  !  !  !  !  !  
Honest: 
Dishonest (4) 
!  !  !  !  !  !  !  
Has Sarah's 
interests at 
heart: Doesn't 
have Sarah's 
interests at 
heart (5) 
!  !  !  !  !  !  !  
Untrustworthy: 
Trustworthy 
(6) 
!  !  !  !  !  !  !  
Inexpert: 
Expert (7) 
!  !  !  !  !  !  !  
Self-centered: 
Not self-
centered (8) 
!  !  !  !  !  !  !  
Concerned 
about Sarah: 
Not concerned 
about Sarah 
(9) 
!  !  !  !  !  !  !  
Honorable: 
Dishonorable 
(10) 
!  !  !  !  !  !  !  
Informed: 
Uninformed 
!  !  !  !  !  !  !  
!
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(11) 
Moral: 
Immoral (12) 
!  !  !  !  !  !  !  
Incompetent: 
Competent 
(13) 
!  !  !  !  !  !  !  
Unethical: 
Ethical (14) 
!  !  !  !  !  !  !  
Insensitive: 
Sensitive (15) 
!  !  !  !  !  !  !  
Bright: Stupid 
(16) 
!  !  !  !  !  !  !  
Phony: 
Genuine (17) 
!  !  !  !  !  !  !  
Not 
understanding: 
Understanding 
(18) 
!  !  !  !  !  !  !  
 
SarahGetVc   
 Very Unlikely 
(1) 
Somewhat 
Unlikely (2) 
Somewhat 
Likely (3) 
Very Likely (4) 
How likely do 
you think Sarah 
would be to get 
the vaccine? (1) 
!  !  !  !  
 
 
YouGetVc   
 Very Unlikely 
(1) 
Somewhat 
Unlikely (2) 
Somewhat 
Likely (3) 
Very Likely (4) 
In thinking 
about what you 
read today (i.e., 
the messages 
from Sarah's 
mother and 
doctor), how 
likely are you 
to get the 
vaccine? (1) 
!  !  !  !  
 
 
BlfsGetVc2 Please indicate how much you agree or disagree with the following 
statements about getting the HPV vaccine. 
!
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 Strongly 
Disagree (1) 
Somewhat 
Disagree (2) 
Somewhat 
Agree (3) 
Strongly Agree 
(4) 
I absolutely will 
not get the HPV 
vaccine. (1) 
!  !  !  !  
I would 
consider getting 
the HPV 
vaccine if I had 
more 
information 
about it. (2) 
!  !  !  !  
I would get the 
HPV vaccine if 
it wasn’t so 
expensive. (3) 
!  !  !  !  
I would get the 
HPV vaccine if 
I had time in my 
busy schedule. 
(4) 
!  !  !  !  
I don’t have 
enough 
information 
about the HPV 
vaccine to 
decide whether 
to get it. (5) 
!  !  !  !  
The HPV 
vaccine is so 
new that I want 
to wait a while 
before deciding 
if I should get 
it. (6) 
!  !  !  !  
Because I’m not 
sexually active 
right now, I 
don’t need the 
HPV vaccine. 
(7) 
!  !  !  !  
 
 
GetVacTim2 Are you seriously thinking of getting the HPV vaccine? 
! Yes, I would probably get the HPV vaccine today. (4) 
! Yes, I would probably get the HPV vaccine within the next 30 days. (1) 
!
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! Yes, I would probably get the HPV vaccine within the next 6 months. (2) 
! No, I am not thinking of getting the HPV vaccine in the future. (3) 
 
Thank you for completing this study!  We really appreciate it!  We would like to 
leave you with some information, in case you would like to learn more about the HPV 
vaccine and where in Lexington you can get it.  The following information about the 
HPV vaccine is taken directly from the Centers for Disease Control and Prevention 
(“CDC”) website.      
Why is the HPV vaccine important? Genital HPV is a common virus that is passed 
from one person to another through direct skin-to-skin contact during sexual activity. 
Most sexually active people will get HPV at some time in their lives, though most will 
never even know it. HPV infection is most common in people in their late teens and early 
20s. There are about 40 types of HPV that can infect the genital areas of men and women. 
Most HPV types cause no symptoms and go away on their own. But some types can 
cause cervical cancer in women and other less common cancers— like cancers of the 
anus, penis, vagina, and vulva and oropharynx (back of throat including base of tongue 
and tonsils). Other types of HPV can cause warts in the genital areas of men and women, 
called genital warts. Genital warts are not life-threatening. But they can cause emotional 
stress and their treatment can be very uncomfortable. Every year, about 12,000 women 
are diagnosed with cervical cancer and 4,000 women die from this disease in the U.S. 
About 1% of sexually active adults in the U.S. have visible genital warts at any point in 
time.   
Which girls/women should receive HPV vaccination? HPV vaccination is 
recommended with either vaccine for 11 and 12 year-old girls. It is also recommended for 
girls and women age 13 through 26 years of age who have not yet been vaccinated or 
completed the vaccine series; HPV vaccine can also be given to girls beginning at age 9 
years.    
Will sexually active females benefit from the vaccine? Ideally females should get 
the vaccine before they become sexually active and exposed to HPV. Females who are 
sexually active may also benefit from vaccination, but they may get less benefit. This is 
because they may have already been exposed to one or more of the HPV types targeted 
by the vaccines. However, few sexually active young women are infected with all HPV 
types prevented by the vaccines, so most young women could still get protection by 
getting vaccinated.   
!
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How effective are the HPV vaccines? The vaccines target the HPV types that 
most commonly cause cervical cancer. One of the vaccines (Gardasil) also protects 
against the HPV types that cause most genital warts. Both vaccines are highly effective in 
preventing the targeted HPV types, as well as the most common health problems caused 
by them.  The vaccines are less effective in preventing HPV-related disease in young 
women who have already been exposed to one or more HPV types. That is because the 
vaccines prevent HPV before a person is exposed to it.  HPV vaccines do not treat 
existing HPV infections or HPV-associated diseases.   
How safe are the HPV vaccines? Both vaccines have been licensed by the Food 
and Drug Administration (FDA). The CDC has approved these vaccines as safe and 
effective. Both vaccines were studied in thousands of people around the world, and these 
studies showed no serious safety concerns. Side effects reported in these studies were 
mild, including pain where the shot was given, fever, dizziness, and nausea. Vaccine 
safety continues to be monitored by CDC and the FDA. More than 46 million doses of 
HPV vaccine have been distributed in the United States as of June 2012.  Fainting, which 
can occur after any medical procedure, has also been noted after HPV vaccination. 
Fainting after any vaccination is more common in adolescents. Because fainting can 
cause falls and injuries, adolescents and adults should be seated or lying down during 
HPV vaccination. Sitting or lying down for about 15 minutes after a vaccination can help 
prevent fainting and injuries.    
The HPV vaccine is available at the University of Kentucky University Health 
Service (859-323-5823) and the Lexington-Fayette County Public Health Department 
((859-252-2371). 
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